Embodiments of the disclosure are generally directed to devices and methods for ablating target tissue within a body vessel. In particular, exemplary embodiments are directed to devices and methods for ablating tissue on a wall of the renal artery, such as to perform renal denervation.
Certain treatments may call for the temporary or permanent interruption or modification of select nerve function. One exemplary treatment is renal nerve ablation, which is sometimes used to treat conditions related to congestive heart failure or hypertension. The kidneys produce a sympathetic response to congestive heart failure, which, among other effects, increases the undesired retention of water and/or sodium. Ablating some of the nerves running to the kidneys may reduce or eliminate this sympathetic function, which may provide a corresponding reduction in the associated undesired symptoms.
Many nerves (and nervous tissue such as brain tissue), including renal nerves, run along the walls of or in close proximity to blood vessels and thus can be accessed intravascularly through the walls of the blood vessels. In some instances, it may be desirable to ablate perivascular nerves and/or tissue using ultrasonic energy. In other instances, the perivascular nerves may be ablated by other means including application of thermal, radiofrequency, laser, microwave, and other related energy sources to the target region.
Conventionally known devices include an ablation catheter having a single electrode at the distal tip, used to deliver radiofrequency (RF) energy, for example, to the target tissue. Sometimes, it is difficult to position the electrode parallel to the vessel wall to obtain an efficient lesion pattern because the ablation catheter may not be controlled to point at the desired locations accurately. Additionally, correct positioning of the electrode may require deflection and/or torquing of the ablation device to place the electrode adjacent a target location within the blood vessel. It is noted that deflection and/or torquing of such ablation devices may include a variety of challenges, for example, potential damage of vessel walls, coagulation of surrounding blood, fouling of the electrode, and so forth.
The disclosure is directed to several alternative designs, materials and methods of manufacturing medical device structures and assemblies for performing nerve ablation and methods for performing nerve ablation.
Accordingly, one illustrative embodiment is an ablation device. The device includes an elongate shaft having a proximal end region and a distal end region. The device also include a handle disposed adjacent to the proximal end, a distal tip including an electrode disposed at the distal end, and a plurality of independently expandable splines adjacent to the distal end.
Another illustrative embodiment is a method of performing nerve ablation. The method can include insertion of an ablation device into a vessel. The ablation device can include an elongate shaft having a proximal end region and a distal end region, a handle disposed adjacent to the proximal end region, a distal tip including an electrode disposed at a distal end and a plurality of independently expandable splines adjacent to the distal end region. The plurality of splines may be disposed in a first delivery position. The method can also include deployment of a first spline to contact the electrode to a wall of the vessel at a first location in a second expanded position. The method can further include application of RF energy to create a first lesion, which is followed by retraction of the first spline to the first delivery position. The method further includes withdrawing the elongate shaft to a first distance.
The method may also include deployment of a second spline of the plurality of splines to contact the electrode to the wall of the vessel in the second expanded position at a second location different from the first location. The method can include application of RF energy to create a second lesion, which is followed by retraction of the second spline to the first delivery position. Subsequently, the ablation device can be withdrawn from the vessel.
The above summary of some example embodiments is not intended to describe each disclosed embodiment or every implementation of the invention.
While embodiments of the present disclosure are amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit aspects of the disclosure to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the present disclosure.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about”, whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the term “about” may be indicative as including numbers that are rounded to the nearest significant figure.
The recitation of numerical ranges by endpoints includes all numbers within that range (e.g., 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
Although some suitable dimensions ranges and/or values pertaining to various components, features and/or specifications are disclosed, one of skill in the art, incited by the present disclosure, would understand desired dimensions, ranges and/or values may deviate from those expressly disclosed.
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
For purposes of this disclosure, “proximal” refers to the end closer to the device operator during use, and “distal” refers to the end farther from the device operator during use.
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The detailed description and the drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention. The illustrative embodiments depicted are intended only as exemplary. Selected features of any illustrative embodiment may be incorporated into an additional embodiment unless clearly stated to the contrary.
Embodiments of the present disclosure are directed to devices and methods for ablating target tissue within a body vessel. Embodiments of the disclosure are directed to devices and methods for ablating perivascular renal nerves from within the renal artery for the treatment of hypertension, congestive heart failure or other diseases or injuries. Embodiments of the disclosure include expandable structures that support alignment of the electrode (s) along the renal artery wall to deliver renal nerve ablation.
While the devices and methods described herein are discussed relative to renal nerve modulation, it is contemplated that the devices and methods may be used in other locations and/or applications where nerve modulation and/or other tissue modulation including, but not limited to, heating, activation, blocking, disrupting, or ablation are desired, such as, but not limited to: blood vessels, urinary vessels, or in other tissues via trocar and cannula access. For example, the devices and methods described herein can be applied to hyperplastic tissue ablation, tumor ablation, benign prostatic hyperplasia therapy, nerve excitation or blocking or ablation, modulation of muscle activity, hyperthermia or other warming of tissues, etc. In some instances, it may be desirable to ablate perivascular renal nerves with radiofrequency (RF) energy. The term modulation refers to ablation and other techniques that may alter the function of nerves and other tissue such as brain tissue or cardiac tissue.
Obtaining good parallel contact with the artery wall during ablation of perivascular renal nerves may be difficult. If contact is variable, the tissue temperatures may not be well controlled, and an ablative temperature may not be achieved in the target tissue, while temperature in other areas, such as portions of the artery wall, may deviate enough to cause unwanted arterial tissue injury. For ideal anatomy, good parallel electrode to vessel contact can be achieved more easily, but especially with tortuous or diseased vessels, there can be very poor contact to effectively and predictably transfer electrical current from an ablation device to the tissue. There is continued need for devices providing improved vessel wall contact for nerve ablation and other therapies.
Embodiments of the disclosure are directed to devices and methods for multi-site RF ablation of perivascular renal nerves for hypertension and other treatments. According to various embodiments, an ablation device may include an elongate shaft having multiple expandable splines near the distal end. The expandable splines may move between a first delivery position and a second expanded position. An RF electrode is mounted on the distal tip of the elongate shaft. The multiple expandable splines can comprise expandable curved, arcuate, or other structures to place the RF electrodes at a desired target location.
When the elongate shaft is deployed, at least one spline may be expanded to come in contact with the artery wall. Such contact between the artery wall and the splines deflects the electrode to contact the artery wall on an opposite side. In some instances, multiple splines may be expanded to place the RF electrode in good parallel contact with the vessel wall.
The elongate shaft can be advanced and deployed in a renal artery to ablate the renal nerves. Activating an RF electrode or combinations of electrodes by energizing from an external energy source may provide one or more discrete RF ablation regions called lesions. Deployment of the ablation device and/or expandable splines can utilize self-expanding elastic forces, push/pull control structures, external retaining and delivery sheaths, and other linkages and structures. An external delivery sheath can be used to protect and constrain the elongate shaft at the distal end during placement and withdrawal. The elongate shaft can be advanced and deployed in a renal artery to ablate the renal nerves. After positioning the shaft's distal end within the renal artery, the delivery sheath can be retracted. Further, the splines may be expanded in a sequential manner allowing the electrode to contact different sites with the renal artery wall.
A proximal end of each of the splines can be connected to a control handle, which may aid in deployment of the splines to the second expanded position. A distal end of each of the splines can be affixed to the distal end region of the elongate shaft adjacent the distal tip. One or more temperature sensors, such as thermocouples, can be provided at the site of the electrode to measure the temperature at or adjacent to the electrode.
The right and left kidneys are supplied with blood from the right and left renal arteries that branch from respective right and left lateral surfaces of the abdominal aorta 20. Each of the right and left renal arteries is directed across the crus of the diaphragm, so as to form nearly a right angle with the abdominal aorta 20. The right and left renal arteries extend generally from the abdominal aorta 20 to respective renal sinuses proximate the hilum 17 of the kidneys, and branch into segmental arteries and then interlobular arteries within the kidney 10. The interlobular arteries radiate outward, penetrating the renal capsule and extending through the renal columns between the renal pyramids. Typically, the kidneys receive about 20% of total cardiac output which, for normal persons, represents about 1200 mL of blood flow through the kidneys per minute.
The primary function of the kidneys is to maintain water and electrolyte balance for the body by controlling the production and concentration of urine. In producing urine, the kidneys excrete wastes such as urea and ammonium. The kidneys also control reabsorption of glucose and amino acids, and are important in the production of hormones including vitamin D, renin and erythropoietin.
An important secondary function of the kidneys is to control metabolic homeostasis of the body. Controlling hemostatic functions include regulating electrolytes, acid-base balance, and blood pressure. For example, the kidneys are responsible for regulating blood volume and pressure by adjusting volume of water lost in the urine and releasing erythropoietin and renin, for example. The kidneys also regulate plasma ion concentrations (e.g., sodium, potassium, chloride ions, and calcium ion levels) by controlling the quantities lost in the urine and the synthesis of calcitrol. Other hemostatic functions controlled by the kidneys include stabilizing blood pH by controlling loss of hydrogen and bicarbonate ions in the urine, conserving valuable nutrients by preventing their excretion, and assisting the liver with detoxification.
Also shown in
The autonomic nervous system of the body controls involuntary actions of the smooth muscles in blood vessels, the digestive system, heart, and glands. The autonomic nervous system is divided into the sympathetic nervous system and the parasympathetic nervous system. In general terms, the parasympathetic nervous system prepares the body for rest by lowering heart rate, lowering blood pressure, and stimulating digestion. The sympathetic nervous system effectuates the body's fight-or-flight response by increasing heart rate, increasing blood pressure, and increasing metabolism.
In the autonomic nervous system, fibers originating from the central nervous system and extending to the various ganglia are referred to as preganglionic fibers, while those extending from the ganglia to the effector organ are referred to as postganglionic fibers. Activation of the sympathetic nervous system is effected through the release of adrenaline (epinephrine) and to a lesser extent norepinephrine from the suprarenal glands 11. This release of adrenaline is triggered by the neurotransmitter acetylcholine released from preganglionic sympathetic nerves.
The kidneys and ureters (not shown) are innervated by the renal nerves 14.
Most of the nerves innervating the renal vasculature are sympathetic postganglionic fibers arising from the superior mesenteric ganglion 26. The renal nerves 14 extend generally axially along the renal arteries 12, enter the kidneys 10 at the hilum 17, follow the branches of the renal arteries 12 within the kidney 10, and extend to individual nephrons. Other renal ganglia, such as the renal ganglia 24, superior mesenteric ganglion 26, the left and right aorticorenal ganglia 22, and celiac ganglia 28 also innervate the renal vasculature. The celiac ganglion 28 is joined by the greater thoracic splanchnic nerve (greater TSN). The aorticorenal ganglia 26 is joined by the lesser thoracic splanchnic nerve (lesser TSN) and innervates the greater part of the renal plexus.
Sympathetic signals to the kidney 10 are communicated via innervated renal vasculature that originates primarily at spinal segments T10-T12 and L1. Parasympathetic signals originate primarily at spinal segments S2-S4 and from the medulla oblongata of the lower brain. Sympathetic nerve traffic travels through the sympathetic trunk ganglia, where some may synapse, while others synapse at the aorticorenal ganglion 22 (via the lesser thoracic splanchnic nerve, i.e., lesser TSN) and the renal ganglion 24 (via the least thoracic splanchnic nerve, i.e., least TSN). The postsynaptic sympathetic signals then travel along nerves 14 of the renal artery 12 to the kidney 10. Presynaptic parasympathetic signals travel to sites near the kidney 10 before they synapse on or near the kidney 10.
With particular reference to
Smooth muscle cells can be stimulated to contract or relax by the autonomic nervous system, but can also react on stimuli from neighboring cells and in response to hormones and blood borne electrolytes and agents (e.g., vasodilators or vasoconstrictors). Specialized smooth muscle cells within the afferent arteriole of the juxtaglomerular apparatus of kidney 10, for example, produces renin which activates the angiotension II system.
The renal nerves 14 innervate the smooth muscle 34 of the renal artery wall 15 and extend lengthwise in a generally axial or longitudinal manner along the renal artery wall 15. The smooth muscle 34 surrounds the renal artery circumferentially, and extends lengthwise in a direction generally transverse to the longitudinal orientation of the renal nerves 14, as is depicted in
The smooth muscle 34 of the renal artery 12 is under involuntary control of the autonomic nervous system. An increase in sympathetic activity, for example, tends to contract the smooth muscle 34, which reduces the diameter of the renal artery lumen 13 and decreases blood perfusion. A decrease in sympathetic activity tends to cause the smooth muscle 34 to relax, resulting in vessel dilation and an increase in the renal artery lumen diameter and blood perfusion. Conversely, increased parasympathetic activity tends to relax the smooth muscle 34, while decreased parasympathetic activity tends to cause smooth muscle contraction.
Adjacent the intima 32 is the media 33, which is the middle layer of the renal artery 12. The media is made up of smooth muscle 34 and elastic tissue. The media 33 can be readily identified by its color and by the transverse arrangement of its fibers. More particularly, the media 33 consists principally of bundles of smooth muscle fibers 34 arranged in a thin plate-like manner or lamellae and disposed circularly around the arterial wall 15. The outermost layer of the renal artery wall 15 is the adventitia 36, which is made up of connective tissue. The adventitia 36 includes fibroblast cells 38 that play an important role in wound healing.
A perivascular region 37 is shown adjacent and peripheral to the adventitia 36 of the renal artery wall 15. A renal nerve 14 is shown proximate the adventitia 36 and passing through a portion of the perivascular region 37. The renal nerve 14 is shown extending substantially longitudinally along the outer wall 15 of the renal artery 12. The main trunk of the renal nerves 14 generally lies in or on the adventitia 36 of the renal artery 12, often passing through the perivascular region 37, with certain branches coursing into the media 33 to enervate the renal artery smooth muscle 34.
Embodiments of the disclosure may be implemented to provide varying degrees of denervation therapy to innervated renal vasculature. For example, embodiments of the disclosure may provide for control of the extent and relative permanency of renal nerve impulse transmission interruption achieved by denervation therapy delivered using a treatment device of the disclosure. The extent and relative permanency of renal nerve injury may be tailored to achieve a desired reduction in sympathetic nerve activity (including a partial or complete block) and to achieve a desired degree of permanency (including temporary or irreversible injury).
As discussed previously, conventionally known devices may include deflection and/or torqueing of ablation devices to place the electrode adjacent a target location within the blood vessel. It is noted, however, that deflection and/or torqueing of the ablation devices may include a variety of challenges. Examples of such challenges are illustrated in
The elongate shaft 502 may have a long, thin, flexible tubular configuration. A person skilled in the art will appreciate that other suitable configurations such as, but not limited to, rectangular, oval, or irregular shapes may also be contemplated. Further, the elongate shaft 502 may have a cross-sectional configuration adapted to be received in a desired vessel, such as a renal artery. For instance, the elongate shaft 502 may be specially sized and configured to accommodate passage through the intravascular path, which leads from a percutaneous access site in, for example, the femoral, brachial, or radial artery, to a targeted treatment site, for example, within a renal artery.
It is contemplated that the stiffness of the elongate shaft 502 may be modified to form an ablation device 500 for use in various vessel diameters. To this end, the material used for manufacturing the elongate shaft 502 may include any suitable biocompatible material such as, but not limited to, polymers, metals, alloys, shape memory alloys, either in combination or alone. In addition to the stiffness requirement, the material employed elongate shaft 502 can also exhibit sufficient flexibility to maneuver through tortuous and/or stenotic lumens.
Although not shown, the elongate shaft 502 may include one or more lumens extending between the proximal end 501 and the distal end 503. For example, the elongate shaft 502 may include a guidewire lumen and/or one or more auxiliary lumens. The guidewire lumen may extend the entire length of the elongate shaft 502 such as in an over-the-wire catheter or may extend only along a distal portion of the elongate shaft 502 such as in a single operator exchange (SOE) catheter. The lumens may have a variety of configurations and/or arrangements. The lumens may be configured in any suitable way such as those ways commonly used for medical device. These examples are not intended to be limiting, but rather examples of some optional configurations.
Further, the elongate shaft 502 includes multiple slots 510a, 510b, and 510c (collectively 510), which are formed on the outer surface 512 of the elongate shaft 502. As shown, the slots 510 may be formed parallel to the longitudinal length of the elongate shaft 502, while extending around the circumference of the elongate shaft 502. While
As described above, the device 500 can further include multiple expandable splines 504. While three expandable splines 504 are illustrated, it is contemplated that the device 500 may include any number of expandable splines 504 desired, but not limited to, one, two, four, five six, or more. In some embodiments, the expandable splines 504 may have a circular cross-sectional shape. However, this is not required. It is contemplated that the expandable splines 504 may have any cross-sectional shape desired, such as, but not limited to, square, rectangular, ovoid, polygonal, etc. In the illustrated embodiment, the expandable splines 504 may be configured to transition between a first delivery position and a second expanded position. In some embodiments, when in the first delivery position, the expandable splines 504 may be oriented approximately equidistant from a central longitudinal axis of the elongate shaft 502, however this is not required. In some embodiments, the splines 504 may be spaced equidistant from one another. However, this is not required. It is contemplated that the splines 504 may be arranged in any manner desired. As shown in
In an embodiment, each expandable spline 504a, 504b, and 504c may rest within their respective slots 510a, 510b, and 510c in the first delivery position. In contrast, in the second expanded state, the splines 504 may extend radially outward from an outer surface of the elongate shaft 502 and out of their respective slots 510 in an arcuate or arch-shaped configuration. The splines 504 may switch to the second expanded position either by a self-expansion mechanism, such as a shape memory material, or by another control mechanism such as push-pull actuation. In the self-expansion mechanism, a portion of each expandable spline 504 may be substantially covered with a sheath, which may allow expansion of the splines 504 when withdrawn. Other control mechanisms may include an actuation mechanism such as handle 514 for manual actuation of the expandable splines 504, which will be discussed below in details. While the splines 504 are described as having an arch-shaped configuration in the expanded position, it is contemplated that the splines 504 may be configured to have different shapes in the expanded configuration, as desired.
The expandable splines 504 may be made from any suitable flexible biocompatible material. Examples may include metals, alloys, polymers, composites, or the like. In an example, the expandable splines 504 are made from a shape memory alloy such as nitinol (NiTi alloy), which may provide super elasticity to the expandable splines 504. Although the material employed should have enough flexibility to form the arch-shaped configuration, it should also have sufficient rigidity to deflect the elongate shaft 502 when in contact with a vessel wall thus allowing the electrode 506 to contact an opposing vessel wall to form one or more lesions. The splines 504 may also be covered with a suitable biocompatible insulation material. Examples may include polymers, composites, or the like. The insulation may prevent or reduce electric conduction between the splines 504 and the vessel wall and/or blood.
The handle 514 may be located at or adjacent to the proximal end region 501, while being operably coupled to the elongate shaft 502. In some embodiments, the handle 514 may be configured to control the distal end region 503 of the elongate shaft 502 and, more specifically, to control the actuation of the expandable splines 504. To accomplish this, the handle 514 may include one or more control elements such as control elements 516a, 516b, and 516c (collectively referred to hereinafter as control elements 516). Each control element 516a, 516b, and 516c may include a button-shaped structure (or other suitably shape structure) that is configured to slide within a slot 518a, 518b, and 518c (collectively 518) in the handle 514. The slots 518 may be sized and shaped to facilitate proximal and distal movement of the control elements 516. In some instances, the control elements 516 may be coupled to the expandable splines 504 such that actuation of the control elements 516 results in a corresponding movement of the expandable splines 504. As shown, an operator may slide the control elements 516a and 516b distally in the directions Da and Db, respectively, to control the arching of the splines 504a and 504b. To this end, control element 516c is in resting position that enables the spline 504c to rest within its slot 510c. In some embodiments, the operator may be able to control how far the splines 504 expand by limiting the distal movement of the control elements 516. For example, control element 516a and control element 516b may be slid to a first and a second position, respectively, which enables expansion of the splines 504a and 504b to a first and a second expanded position, respectively. Therefore, sliding of each control element 516 may control the expansion of one spline 504. While the control elements 516 have been described as expanding the splines 504 upon distal actuation of the control elements 516, it is contemplated the reverse configuration may also be used and proximal actuation of the control elements 516 will result in the expansion of the splines 504. In some instances, the control elements 516 may include features to allow the splines 504 to be adjusted one or more discrete steps or intervals. In other instances, the control elements 516 may allow the expandable splines 504 to be infinitely adjustable.
Although a slider-based handle is employed or shown to actuate the splines 504, a variety of different mechanisms may be used to actuate the expandable splines 504. For example, the handle 514 may be mechanical or electronic, with varying means of actuation—servo motors, springs, rotary/gear-based, and so forth. In some instances, a push-pull mechanism different from the slider mechanism described above may be used to switch the expandable splines 504 to their second expanded state, although the two mechanisms may be provided on the handle 514 located at the proximal end of the elongate shaft 502. According to some other embodiment, a push-pull mechanism may be provided at a proximal end (not shown) of a delivery sheath, such as sheath 606 shown in
The ablation device 500 may further include an electrode 506 disposed adjacent the distal tip 505 of the elongate shaft 502, which may be employed to ablate the renal nerves. In some embodiments, the electrode 506 may employ radiofrequency energy to ablate the tissue and/or renal nerves. The RF electrode 36 may be made from a suitably conductive metal such as platinum gold, stainless steel, cobalt alloys, or other non-oxidizing materials. While the electrode 506 is described as radiofrequency electrode, it is contemplated that other methods and devices for raising the temperature of the nerves may be used such as, but not limited to, ultrasound, microwave, or other acoustic, optical, electrical current, direct contact heating, or other heating. While not explicitly shown, the electrode 506 may be connected to an energy source or a power and control unit configured through one or more electrical conductors. In some instances, the power and control unit may be a source of RF energy. Furthermore, while not explicitly shown, in some embodiments, the ablation device may include more than one electrode 506.
Further, in some embodiments, a sensor 508 may be disposed within the electrode 506. In some instances, the sensor 508 may include a temperature sensor such as a thermocouple. However, other suitable sensors such as an impedance sensor may also be employed. The sensor 508 may provide feedback, such as the temperature or impedance measurements, to the operator and/or a control unit for monitoring the ablation procedure. For example, the feedback may be indicative of good electrode 506 to vessel contact and/or lesion size. This may facilitate the proper alignment of the electrode 506 with the target tissue and also avoids over heating of the tissue during a renal denervation procedure. In one embodiment, the heat generated at the electrode 506 is measured by the sensor 508, which may help identify if there is suitable contact with the tissue being ablated. For example, a tip suspended in the blood (i.e., not in contact with the vessel wall, like in
As alluded to above, the device 500 may also detect the impedance level while delivering RF energy to the tissue. For instance, an electrode 506 suspended in the blood may exhibit a different impedance level than the electrode 506 having contact with tissue. The impedance can be measured using any conventionally known devices.
Other suitable ways of detecting the desired placement of electrode 506 with the vessel wall may include, but not limited to, imaging methods such as X-Ray, fluoroscopy, and so forth. According to an example, a radiopaque marker may be used to identify the location of the electrode 506 within the vessel. These are just examples and are not limiting the scope of present disclosure.
Turning now to
In the illustrated embodiment, the device 500 may be introduced within the artery 600 using a device such as a delivery sheath 606. As shown, the renal ablation device 500 may be slidably disposed within a lumen 608 of the delivery sheath 606. The dimensions of the delivery sheath 606 should be sufficient to carry the device 500 inside the lumen 608 while being navigated through the artery 600. An appropriate actuation mechanism may be provided at the proximal end of the elongate shaft 502. The actuation mechanism may help in deployment the elongate shaft 502 at the target location, while exposing the expandable splines 504 and the electrode 506 to the surrounding vessel.
In the present embodiment, materials used to manufacture the delivery sheath 606 may include a rigid and/or a flexible material either in combination or alone. Additionally, exemplary materials may include metals, polymers, alloys, or composite, either in combination or alone. In an example, an appropriate material to constitute the delivery sheath 606 may include a flexible polymer. Other suitable material may also be contemplated without departing from the scope and spirit of the disclosure.
Referring to
As discussed previously, the delivery sheath 606 is employed to introduce the elongate shaft 502 within the renal artery 600. Once the electrode 506 is positioned at the target location adjacent the artery wall 602, RF energy may be supplied to the electrode 506. As the energy is radiated from the electrode 506, the electrode 506 may heat up. While not shown explicitly, the device 500, along with the temperature sensor 508, may also include a cooling mechanism to regulate the temperature of the electrode 506. Such mechanisms may include any suitable cooling method such as infusion of fluid around the electrode, which circulates the blood around the electrode 506 that may result in lowering the temperature around the electrode 506.
Although single spline 504a is expanded in the present embodiment, it should be noted that two or more splines 504 may be expanded simultaneously such as to place the electrode 506 at a desired target location. To this end, two or more splines 504 may be expanded either simultaneously or sequentially. In addition, the amount of energy delivered to the electrode 506 may be determined by the desired treatment as well as the measured temperature provided by the sensor 508.
Turning now to
The delivery sheath 606 is employed to introduce the elongate shaft 502 within the renal artery 600. Once the electrode 506 is positioned at the target location adjacent the artery wall 602, RF energy may be supplied to the electrode 506. As the energy is radiated from the electrode 506, the electrode 506 may heat up. While not shown explicitly, the device 500, along with the temperature sensor 508, may also include a cooling mechanism to regulate the temperature of the electrode 506. Such mechanisms may include any suitable cooling method such as infusion of fluid around the electrode, which circulates the blood around the electrode 506 that may result in lowering the temperature around the electrode 506.
For the purpose of illustration, the spline 506c is depicted to form the arch-shaped configuration, however, it should be noted that the spline 506c is arched in transverse plane of the elongate shaft 502. To this end, the spline 506c may be assumed to contact the artery wall at a point (not shown) at an angle of approximately 90 degrees to the contact A that is made by spline 504a (as discussed in
For the purpose of illustration, the spline 506d is depicted to form the arch-shaped configuration, however, it should be noted that the spline 506d is arched in transverse plane of the elongate shaft 502. To this end, the spline 506d may be assumed to contact the artery wall at a point (not shown) at an angle of 90 degrees to the contact A that is made by spline 504a (as discussed in
According to a method of performing renal ablation, the device 500 may be inserted into the renal artery 600 and advanced to the desired treatment region. Subsequently, a first spline, such as the spline 504a, may be deployed to contact the electrode 506 to the renal artery wall 602 at a first location such as point A, as shown in
Further, a second spline such as spline 504b may be deployed to contact the wall 602 at a second location such as point B, as shown in 6B. Next, the RF energy may be applied to create a second lesion, which is followed by retraction of the second spline 504b to the first delivery position. Here, the deployment of one or more splines 504 to the second expanded position biases the electrode 506 toward the wall 602 of the renal artery 600 in a direction opposite the deployed spline 504. This way the sequential deployment of splines 504 may form multiple lesions on the wall 602. This may be repeated as many times as necessary to form the desired number and/or size of lesions. In some instances, the elongate shaft 502 may be longitudinally displaced in the artery 600 after the formation of a lesion. This may result in longitudinally spaced lesions. It is contemplated that the lesions may be formed along a single side of the artery 600 or the lesions may be spaced about the circumference of the artery 600. In some instances, the elongate shaft 502 may be longitudinally displaced after each lesion, and each spline 504 may be actuated sequentially to form lesions in a generally helical pattern. It is further contemplated that the temperature response and/or the impedance level may be checked prior to actuating a different spine 504 or relocating the elongate shaft 502.
Various embodiments disclosed herein are generally described in the context of ablation of perivascular renal nerves for control of hypertension. It is understood, however, that embodiments of the disclosure have applicability in other contexts, such as performing ablation from within other vessels of the body, including other arteries, veins, and vasculature (e.g., cardiac and urinary vasculature and vessels), and other tissues of the body, including various organs.
It is to be understood that even though numerous characteristics of various embodiments have been set forth in the foregoing description, together with details of the structure and function of various embodiments, this detailed description is illustrative only, and changes may be made in detail, especially in matters of structure and arrangements of parts illustrated by the various embodiments to the full extent indicated by the broad general meaning of the terms in which the appended claims are expressed.
This application claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Application No. 61/794,020, filed Mar. 15, 2013, the entire disclosure of which is herein incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
164184 | Kidder | Jun 1875 | A |
1167014 | O'Brien | Jan 1916 | A |
2505358 | Gusberg et al. | Apr 1950 | A |
2701559 | Cooper | Feb 1955 | A |
3108593 | Glassman | Oct 1963 | A |
3108594 | Glassman | Oct 1963 | A |
3540431 | Mobin | Nov 1970 | A |
3952747 | Kimmell | Apr 1976 | A |
3996938 | Clark, III | Dec 1976 | A |
4046150 | Schwartz et al. | Sep 1977 | A |
4290427 | Chin | Sep 1981 | A |
4402686 | Medel | Sep 1983 | A |
4483341 | Witteles et al. | Nov 1984 | A |
4574804 | Kurwa | Mar 1986 | A |
4587975 | Salo et al. | May 1986 | A |
4649936 | Ungar et al. | Mar 1987 | A |
4682596 | Bales et al. | Jul 1987 | A |
4709698 | Johnston et al. | Dec 1987 | A |
4765331 | Petruzzi et al. | Aug 1988 | A |
4770653 | Shturman | Sep 1988 | A |
4784132 | Fox et al. | Nov 1988 | A |
4784162 | Ricks et al. | Nov 1988 | A |
4785806 | Deckelbaum et al. | Nov 1988 | A |
4788975 | Shturman et al. | Dec 1988 | A |
4790310 | Ginsburg et al. | Dec 1988 | A |
4799479 | Spears | Jan 1989 | A |
4823791 | D'Amelio et al. | Apr 1989 | A |
4830003 | Wolff et al. | May 1989 | A |
4849484 | Heard | Jul 1989 | A |
4862886 | Clarke et al. | Sep 1989 | A |
4887605 | Angelsen et al. | Dec 1989 | A |
4920979 | Bullara et al. | May 1990 | A |
4938766 | Jarvik | Jul 1990 | A |
4955377 | Lennox et al. | Sep 1990 | A |
4976711 | Parins et al. | Dec 1990 | A |
5034010 | Kittrell et al. | Jul 1991 | A |
5052402 | Bencini et al. | Oct 1991 | A |
5053033 | Clarke et al. | Oct 1991 | A |
5071424 | Reger et al. | Dec 1991 | A |
5074871 | Groshong et al. | Dec 1991 | A |
5098429 | Sterzer et al. | Mar 1992 | A |
5098431 | Rydell | Mar 1992 | A |
5109859 | Jenkins | May 1992 | A |
5125928 | Parins et al. | Jun 1992 | A |
5129396 | Rosen et al. | Jul 1992 | A |
5139496 | Hed | Aug 1992 | A |
5143836 | Hartman et al. | Sep 1992 | A |
5156610 | Reger et al. | Oct 1992 | A |
5158564 | Schnepp-Pesch | Oct 1992 | A |
5170802 | Mehra | Dec 1992 | A |
5178620 | Eggers et al. | Jan 1993 | A |
5178625 | Groshong et al. | Jan 1993 | A |
5190540 | Lee | Mar 1993 | A |
5211651 | Reger et al. | May 1993 | A |
5234407 | Teirstein et al. | Aug 1993 | A |
5242441 | Avitall | Sep 1993 | A |
5251634 | Weinberg et al. | Oct 1993 | A |
5255679 | Imran | Oct 1993 | A |
5263493 | Avitall | Nov 1993 | A |
5267954 | Nita et al. | Dec 1993 | A |
5277201 | Stern et al. | Jan 1994 | A |
5282484 | Reger et al. | Feb 1994 | A |
5286254 | Shapland et al. | Feb 1994 | A |
5295484 | Marcus | Mar 1994 | A |
5297564 | Love et al. | Mar 1994 | A |
5300068 | Rosar et al. | Apr 1994 | A |
5301683 | Durkan | Apr 1994 | A |
5304115 | Pflueger et al. | Apr 1994 | A |
5304121 | Sahatjian | Apr 1994 | A |
5304171 | Gregory et al. | Apr 1994 | A |
5304173 | Kittrell et al. | Apr 1994 | A |
5306250 | March et al. | Apr 1994 | A |
5312328 | Nita et al. | May 1994 | A |
5314466 | Stern et al. | May 1994 | A |
5322064 | Lundquist | Jun 1994 | A |
5324255 | Passafaro et al. | Jun 1994 | A |
5326341 | Lew et al. | Jul 1994 | A |
5326342 | Pflueger et al. | Jul 1994 | A |
5330518 | Neilson et al. | Jul 1994 | A |
5333614 | Feiring | Aug 1994 | A |
5342292 | Nita et al. | Aug 1994 | A |
5344395 | Whalen et al. | Sep 1994 | A |
5364392 | Warner et al. | Nov 1994 | A |
5365172 | Hrovat et al. | Nov 1994 | A |
5368557 | Nita et al. | Nov 1994 | A |
5368558 | Nita et al. | Nov 1994 | A |
5380274 | Nita et al. | Jan 1995 | A |
5380319 | Saito et al. | Jan 1995 | A |
5382228 | Nita et al. | Jan 1995 | A |
5383874 | Jackson et al. | Jan 1995 | A |
5383917 | Desai et al. | Jan 1995 | A |
5397301 | Pflueger et al. | Mar 1995 | A |
5397339 | Desai | Mar 1995 | A |
5401272 | Perkins et al. | Mar 1995 | A |
5403311 | Abele et al. | Apr 1995 | A |
5405318 | Nita et al. | Apr 1995 | A |
5405346 | Grundy et al. | Apr 1995 | A |
5409000 | Imran | Apr 1995 | A |
5417672 | Nita et al. | May 1995 | A |
5419767 | Eggers et al. | May 1995 | A |
5427118 | Nita et al. | Jun 1995 | A |
5432876 | Appeldorn et al. | Jul 1995 | A |
5441498 | Perkins et al. | Aug 1995 | A |
5447509 | Mills et al. | Sep 1995 | A |
5451207 | Yock et al. | Sep 1995 | A |
5453091 | Taylor et al. | Sep 1995 | A |
5454788 | Walker et al. | Oct 1995 | A |
5454809 | Janssen | Oct 1995 | A |
5455029 | Hartman et al. | Oct 1995 | A |
5456682 | Edwards et al. | Oct 1995 | A |
5457042 | Hartman et al. | Oct 1995 | A |
5471982 | Edwards et al. | Dec 1995 | A |
5474530 | Passafaro et al. | Dec 1995 | A |
5478351 | Meade et al. | Dec 1995 | A |
5496311 | Abele et al. | Mar 1996 | A |
5496312 | Klicek et al. | Mar 1996 | A |
5498261 | Strul | Mar 1996 | A |
5505201 | Grill et al. | Apr 1996 | A |
5505730 | Edwards | Apr 1996 | A |
5507744 | Tay et al. | Apr 1996 | A |
5522873 | Jackman et al. | Jun 1996 | A |
5531520 | Grimson et al. | Jul 1996 | A |
5540656 | Pflueger et al. | Jul 1996 | A |
5540679 | Fram et al. | Jul 1996 | A |
5540681 | Strul et al. | Jul 1996 | A |
5542917 | Nita et al. | Aug 1996 | A |
5545161 | Imran | Aug 1996 | A |
5562100 | Kittrell et al. | Oct 1996 | A |
5571122 | Kelly et al. | Nov 1996 | A |
5571151 | Gregory | Nov 1996 | A |
5573531 | Gregory et al. | Nov 1996 | A |
5573533 | Strul | Nov 1996 | A |
5584831 | McKay | Dec 1996 | A |
5584872 | Lafontaine et al. | Dec 1996 | A |
5588962 | Nicholas et al. | Dec 1996 | A |
5599346 | Edwards et al. | Feb 1997 | A |
5601526 | Chapelon et al. | Feb 1997 | A |
5609606 | O'Boyle et al. | Mar 1997 | A |
5626576 | Janssen | May 1997 | A |
5630837 | Crowley | May 1997 | A |
5637090 | McGee et al. | Jun 1997 | A |
5643255 | Organ | Jul 1997 | A |
5643297 | Nordgren et al. | Jul 1997 | A |
5647847 | Lafontaine et al. | Jul 1997 | A |
5649923 | Gregory et al. | Jul 1997 | A |
5651780 | Jackson et al. | Jul 1997 | A |
5653684 | Laptewicz et al. | Aug 1997 | A |
5662671 | Barbut et al. | Sep 1997 | A |
5665062 | Houser | Sep 1997 | A |
5665098 | Kelly et al. | Sep 1997 | A |
5666964 | Meilus | Sep 1997 | A |
5667490 | Keith et al. | Sep 1997 | A |
5672174 | Gough et al. | Sep 1997 | A |
5676693 | Lafontaine | Oct 1997 | A |
5678296 | Fleischhacker et al. | Oct 1997 | A |
5681282 | Eggers et al. | Oct 1997 | A |
RE35656 | Feinberg | Nov 1997 | E |
5688266 | Edwards et al. | Nov 1997 | A |
5693015 | Walker et al. | Dec 1997 | A |
5693029 | Leonhardt et al. | Dec 1997 | A |
5693043 | Kittrell et al. | Dec 1997 | A |
5693082 | Warner et al. | Dec 1997 | A |
5695504 | Gifford et al. | Dec 1997 | A |
5697369 | Long, Jr. et al. | Dec 1997 | A |
5697909 | Eggers et al. | Dec 1997 | A |
5702386 | Stern et al. | Dec 1997 | A |
5702433 | Taylor et al. | Dec 1997 | A |
5706809 | Littmann et al. | Jan 1998 | A |
5713942 | Stern et al. | Feb 1998 | A |
5715819 | Svenson et al. | Feb 1998 | A |
5735846 | Panescu et al. | Apr 1998 | A |
5741214 | Ouchi et al. | Apr 1998 | A |
5741248 | Stern et al. | Apr 1998 | A |
5741249 | Moss et al. | Apr 1998 | A |
5743903 | Stern et al. | Apr 1998 | A |
5748347 | Erickson | May 1998 | A |
5749914 | Janssen | May 1998 | A |
5755682 | Knudson et al. | May 1998 | A |
5755715 | Stern et al. | May 1998 | A |
5755753 | Knowlton et al. | May 1998 | A |
5769847 | Panescu et al. | Jun 1998 | A |
5769880 | Truckai et al. | Jun 1998 | A |
5775338 | Hastings | Jul 1998 | A |
5776174 | Van Tassel | Jul 1998 | A |
5779698 | Clayman et al. | Jul 1998 | A |
5782760 | Schaer | Jul 1998 | A |
5785702 | Murphy et al. | Jul 1998 | A |
5797849 | Vesely et al. | Aug 1998 | A |
5797903 | Swanson et al. | Aug 1998 | A |
5800484 | Gough et al. | Sep 1998 | A |
5800494 | Campbell et al. | Sep 1998 | A |
5810802 | Panescu et al. | Sep 1998 | A |
5810803 | Moss et al. | Sep 1998 | A |
5810810 | Tay et al. | Sep 1998 | A |
5817092 | Behl | Oct 1998 | A |
5817113 | Gifford et al. | Oct 1998 | A |
5817144 | Gregory et al. | Oct 1998 | A |
5823956 | Roth et al. | Oct 1998 | A |
5827203 | Nita et al. | Oct 1998 | A |
5827268 | Laufer | Oct 1998 | A |
5829447 | Stevens et al. | Nov 1998 | A |
5830213 | Panescu et al. | Nov 1998 | A |
5830222 | Makower | Nov 1998 | A |
5832228 | Holden et al. | Nov 1998 | A |
5833593 | Liprie | Nov 1998 | A |
5836874 | Swanson et al. | Nov 1998 | A |
5840076 | Swanson et al. | Nov 1998 | A |
5843016 | Lugnani et al. | Dec 1998 | A |
5846238 | Jackson et al. | Dec 1998 | A |
5846239 | Swanson et al. | Dec 1998 | A |
5846245 | McCarthy et al. | Dec 1998 | A |
5848969 | Panescu et al. | Dec 1998 | A |
5853411 | Whayne et al. | Dec 1998 | A |
5855614 | Stevens et al. | Jan 1999 | A |
5860974 | Abele | Jan 1999 | A |
5865801 | Houser | Feb 1999 | A |
5868735 | Lafontaine et al. | Feb 1999 | A |
5868736 | Swanson et al. | Feb 1999 | A |
5871483 | Jackson et al. | Feb 1999 | A |
5871524 | Knowlton et al. | Feb 1999 | A |
5875782 | Ferrari et al. | Mar 1999 | A |
5876369 | Houser | Mar 1999 | A |
5876374 | Alba et al. | Mar 1999 | A |
5876397 | Edelman et al. | Mar 1999 | A |
5879348 | Owens et al. | Mar 1999 | A |
5891114 | Chien et al. | Apr 1999 | A |
5891135 | Jackson et al. | Apr 1999 | A |
5891136 | McGee et al. | Apr 1999 | A |
5891138 | Tu et al. | Apr 1999 | A |
5895378 | Nita | Apr 1999 | A |
5897552 | Edwards et al. | Apr 1999 | A |
5902328 | Lafontaine et al. | May 1999 | A |
5904651 | Swanson et al. | May 1999 | A |
5904667 | Falwell et al. | May 1999 | A |
5904697 | Gifford et al. | May 1999 | A |
5904709 | Arndt et al. | May 1999 | A |
5906614 | Stern et al. | May 1999 | A |
5906623 | Peterson | May 1999 | A |
5906636 | Casscells et al. | May 1999 | A |
5916192 | Nita et al. | Jun 1999 | A |
5916227 | Keith et al. | Jun 1999 | A |
5916239 | Geddes et al. | Jun 1999 | A |
5919219 | Knowlton et al. | Jul 1999 | A |
5924424 | Stevens et al. | Jul 1999 | A |
5925038 | Panescu et al. | Jul 1999 | A |
5934284 | Plaia et al. | Aug 1999 | A |
5935063 | Nguyen | Aug 1999 | A |
5938670 | Keith et al. | Aug 1999 | A |
5947977 | Slepian et al. | Sep 1999 | A |
5948011 | Knowlton et al. | Sep 1999 | A |
5951494 | Wang et al. | Sep 1999 | A |
5951539 | Nita et al. | Sep 1999 | A |
5954717 | Behl et al. | Sep 1999 | A |
5957882 | Nita et al. | Sep 1999 | A |
5957941 | Ream et al. | Sep 1999 | A |
5957969 | Warner et al. | Sep 1999 | A |
5961513 | Swanson et al. | Oct 1999 | A |
5964757 | Ponzi et al. | Oct 1999 | A |
5967976 | Larsen et al. | Oct 1999 | A |
5967978 | Littmann et al. | Oct 1999 | A |
5967984 | Chu et al. | Oct 1999 | A |
5971975 | Mills et al. | Oct 1999 | A |
5972026 | Laufer et al. | Oct 1999 | A |
5980563 | Tu et al. | Nov 1999 | A |
5989208 | Nita et al. | Nov 1999 | A |
5989284 | Laufer | Nov 1999 | A |
5993462 | Pomeranz et al. | Nov 1999 | A |
5997497 | Nita et al. | Dec 1999 | A |
5999678 | Murphy et al. | Dec 1999 | A |
6004269 | Crowley et al. | Dec 1999 | A |
6004316 | Laufer et al. | Dec 1999 | A |
6007514 | Nita | Dec 1999 | A |
6010522 | Barbut et al. | Jan 2000 | A |
6013033 | Berger et al. | Jan 2000 | A |
6014590 | Whayne et al. | Jan 2000 | A |
6022309 | Celliers et al. | Feb 2000 | A |
6024740 | Lesh | Feb 2000 | A |
6030611 | Gorecki et al. | Feb 2000 | A |
6032675 | Rubinsky et al. | Mar 2000 | A |
6033397 | Laufer | Mar 2000 | A |
6033398 | Farley et al. | Mar 2000 | A |
6036687 | Laufer et al. | Mar 2000 | A |
6036689 | Tu et al. | Mar 2000 | A |
6041260 | Stern et al. | Mar 2000 | A |
6050994 | Sherman et al. | Apr 2000 | A |
6056744 | Edwards | May 2000 | A |
6056746 | Goble et al. | May 2000 | A |
6063085 | Tay et al. | May 2000 | A |
6066096 | Smith et al. | May 2000 | A |
6066139 | Ryan et al. | May 2000 | A |
6068638 | Makower | May 2000 | A |
6068653 | Lafontaine | May 2000 | A |
6071277 | Farley et al. | Jun 2000 | A |
6071278 | Panescu et al. | Jun 2000 | A |
6078839 | Carson | Jun 2000 | A |
6079414 | Roth | Jun 2000 | A |
6080171 | Keith et al. | Jun 2000 | A |
6081749 | Ingle et al. | Jun 2000 | A |
6086581 | Reynolds et al. | Jul 2000 | A |
6093166 | Knudson et al. | Jul 2000 | A |
6096021 | Helm et al. | Aug 2000 | A |
6099526 | Whayne et al. | Aug 2000 | A |
6102908 | Tu et al. | Aug 2000 | A |
6106477 | Miesel et al. | Aug 2000 | A |
6110187 | Donlon et al. | Aug 2000 | A |
6114311 | Parmacek et al. | Sep 2000 | A |
6117101 | Diederich et al. | Sep 2000 | A |
6117128 | Gregory | Sep 2000 | A |
6120476 | Fung et al. | Sep 2000 | A |
6120516 | Selmon et al. | Sep 2000 | A |
6121775 | Pearlman | Sep 2000 | A |
6123679 | Lafaut et al. | Sep 2000 | A |
6123682 | Knudson et al. | Sep 2000 | A |
6123702 | Swanson et al. | Sep 2000 | A |
6123703 | Tu et al. | Sep 2000 | A |
6123718 | Tu et al. | Sep 2000 | A |
6129725 | Tu et al. | Oct 2000 | A |
6135997 | Laufer et al. | Oct 2000 | A |
6142991 | Schatzberger et al. | Nov 2000 | A |
6142993 | Whayne et al. | Nov 2000 | A |
6149647 | Tu et al. | Nov 2000 | A |
6152899 | Farley et al. | Nov 2000 | A |
6152912 | Jansen et al. | Nov 2000 | A |
6156046 | Passafaro et al. | Dec 2000 | A |
6158250 | Tibbals et al. | Dec 2000 | A |
6159187 | Park et al. | Dec 2000 | A |
6159225 | Makower | Dec 2000 | A |
6161048 | Sluijter et al. | Dec 2000 | A |
6162184 | Swanson et al. | Dec 2000 | A |
6165163 | Chien et al. | Dec 2000 | A |
6165172 | Farley et al. | Dec 2000 | A |
6165187 | Reger et al. | Dec 2000 | A |
6168594 | Lafontaine et al. | Jan 2001 | B1 |
6171321 | Gifford, III et al. | Jan 2001 | B1 |
6179832 | Jones et al. | Jan 2001 | B1 |
6179835 | Panescu et al. | Jan 2001 | B1 |
6179859 | Bates et al. | Jan 2001 | B1 |
6183468 | Swanson et al. | Feb 2001 | B1 |
6183486 | Snow et al. | Feb 2001 | B1 |
6190379 | Heuser et al. | Feb 2001 | B1 |
6191862 | Swanson et al. | Feb 2001 | B1 |
6197021 | Panescu et al. | Mar 2001 | B1 |
6200266 | Shokrollahi et al. | Mar 2001 | B1 |
6203537 | Adrian | Mar 2001 | B1 |
6203561 | Ramee et al. | Mar 2001 | B1 |
6210406 | Webster | Apr 2001 | B1 |
6211247 | Goodman | Apr 2001 | B1 |
6217576 | Tu et al. | Apr 2001 | B1 |
6219577 | Brown, III et al. | Apr 2001 | B1 |
6228076 | Winston et al. | May 2001 | B1 |
6228109 | Tu et al. | May 2001 | B1 |
6231516 | Keilman et al. | May 2001 | B1 |
6231587 | Makower | May 2001 | B1 |
6235044 | Root et al. | May 2001 | B1 |
6236883 | Ciaccio et al. | May 2001 | B1 |
6237605 | Vaska et al. | May 2001 | B1 |
6238389 | Paddock et al. | May 2001 | B1 |
6238392 | Long | May 2001 | B1 |
6241666 | Pomeranz et al. | Jun 2001 | B1 |
6241753 | Knowlton | Jun 2001 | B1 |
6245020 | Moore et al. | Jun 2001 | B1 |
6245045 | Stratienko | Jun 2001 | B1 |
6248126 | Lesser et al. | Jun 2001 | B1 |
6251128 | Knopp et al. | Jun 2001 | B1 |
6258087 | Edwards et al. | Jul 2001 | B1 |
6263248 | Farley et al. | Jul 2001 | B1 |
6273886 | Edwards et al. | Aug 2001 | B1 |
6280466 | Kugler et al. | Aug 2001 | B1 |
6283935 | Laufer et al. | Sep 2001 | B1 |
6283959 | Lalonde et al. | Sep 2001 | B1 |
6284743 | Parmacek et al. | Sep 2001 | B1 |
6287304 | Eggers | Sep 2001 | B1 |
6287323 | Hammerslag | Sep 2001 | B1 |
6290696 | Lafontaine | Sep 2001 | B1 |
6292695 | Webster, Jr. et al. | Sep 2001 | B1 |
6293942 | Goble et al. | Sep 2001 | B1 |
6293943 | Panescu et al. | Sep 2001 | B1 |
6296619 | Brisken et al. | Oct 2001 | B1 |
6298256 | Meyer | Oct 2001 | B1 |
6299379 | Lewis | Oct 2001 | B1 |
6299623 | Wulfman | Oct 2001 | B1 |
6309379 | Willard et al. | Oct 2001 | B1 |
6309399 | Barbut et al. | Oct 2001 | B1 |
6311090 | Knowlton | Oct 2001 | B1 |
6317615 | KenKnight et al. | Nov 2001 | B1 |
6319242 | Patterson et al. | Nov 2001 | B1 |
6319251 | Tu et al. | Nov 2001 | B1 |
6322559 | Daulton et al. | Nov 2001 | B1 |
6325797 | Stewart et al. | Dec 2001 | B1 |
6325799 | Goble | Dec 2001 | B1 |
6328699 | Eigler et al. | Dec 2001 | B1 |
6346074 | Roth | Feb 2002 | B1 |
6346104 | Daly et al. | Feb 2002 | B2 |
6350248 | Knudson et al. | Feb 2002 | B1 |
6350276 | Knowlton | Feb 2002 | B1 |
6353751 | Swanson et al. | Mar 2002 | B1 |
6355029 | Joye et al. | Mar 2002 | B1 |
6357447 | Swanson et al. | Mar 2002 | B1 |
6361519 | Knudson et al. | Mar 2002 | B1 |
6364840 | Crowley | Apr 2002 | B1 |
6371965 | Gifford, III et al. | Apr 2002 | B2 |
6375668 | Gifford et al. | Apr 2002 | B1 |
6377854 | Knowlton | Apr 2002 | B1 |
6377855 | Knowlton | Apr 2002 | B1 |
6379352 | Reynolds et al. | Apr 2002 | B1 |
6379373 | Sawhney et al. | Apr 2002 | B1 |
6381497 | Knowlton | Apr 2002 | B1 |
6381498 | Knowlton | Apr 2002 | B1 |
6383151 | Diederich et al. | May 2002 | B1 |
6387105 | Gifford, III et al. | May 2002 | B1 |
6387380 | Knowlton | May 2002 | B1 |
6389311 | Whayne et al. | May 2002 | B1 |
6389314 | Feiring | May 2002 | B2 |
6391024 | Sun et al. | May 2002 | B1 |
6394096 | Constantz | May 2002 | B1 |
6394956 | Chandrasekaran et al. | May 2002 | B1 |
6398780 | Farley et al. | Jun 2002 | B1 |
6398782 | Pecor et al. | Jun 2002 | B1 |
6398792 | O'Connor | Jun 2002 | B1 |
6401720 | Stevens et al. | Jun 2002 | B1 |
6402719 | Ponzi et al. | Jun 2002 | B1 |
6405090 | Knowlton | Jun 2002 | B1 |
6409723 | Edwards | Jun 2002 | B1 |
6413255 | Stern | Jul 2002 | B1 |
6421559 | Pearlman | Jul 2002 | B1 |
6423057 | He et al. | Jul 2002 | B1 |
6425867 | Vaezy et al. | Jul 2002 | B1 |
6425912 | Knowlton | Jul 2002 | B1 |
6427118 | Suzuki | Jul 2002 | B1 |
6428534 | Joye et al. | Aug 2002 | B1 |
6428536 | Panescu et al. | Aug 2002 | B2 |
6430446 | Knowlton | Aug 2002 | B1 |
6432102 | Joye et al. | Aug 2002 | B2 |
6436056 | Wang et al. | Aug 2002 | B1 |
6438424 | Knowlton | Aug 2002 | B1 |
6440125 | Rentrop | Aug 2002 | B1 |
6442413 | Silver | Aug 2002 | B1 |
6443965 | Gifford, III et al. | Sep 2002 | B1 |
6445939 | Swanson et al. | Sep 2002 | B1 |
6447505 | McGovern et al. | Sep 2002 | B2 |
6447509 | Bonnet et al. | Sep 2002 | B1 |
6451034 | Gifford, III et al. | Sep 2002 | B1 |
6451044 | Naghavi et al. | Sep 2002 | B1 |
6453202 | Knowlton | Sep 2002 | B1 |
6454737 | Nita et al. | Sep 2002 | B1 |
6454757 | Nita et al. | Sep 2002 | B1 |
6454775 | Demarais et al. | Sep 2002 | B1 |
6458098 | Kanesaka | Oct 2002 | B1 |
6461378 | Knowlton | Oct 2002 | B1 |
6468276 | McKay | Oct 2002 | B1 |
6468297 | Williams et al. | Oct 2002 | B1 |
6470216 | Knowlton | Oct 2002 | B1 |
6470219 | Edwards et al. | Oct 2002 | B1 |
6471696 | Berube et al. | Oct 2002 | B1 |
6475213 | Whayne et al. | Nov 2002 | B1 |
6475215 | Tanrisever | Nov 2002 | B1 |
6475238 | Fedida et al. | Nov 2002 | B1 |
6477426 | Fenn et al. | Nov 2002 | B1 |
6480745 | Nelson et al. | Nov 2002 | B2 |
6481704 | Koster et al. | Nov 2002 | B1 |
6482202 | Goble et al. | Nov 2002 | B1 |
6484052 | Visuri et al. | Nov 2002 | B1 |
6485489 | Teirstein et al. | Nov 2002 | B2 |
6488679 | Swanson et al. | Dec 2002 | B1 |
6489307 | Phillips et al. | Dec 2002 | B1 |
6491705 | Gifford, III et al. | Dec 2002 | B2 |
6494891 | Cornish et al. | Dec 2002 | B1 |
6497711 | Plaia et al. | Dec 2002 | B1 |
6500172 | Panescu et al. | Dec 2002 | B1 |
6500174 | Maguire et al. | Dec 2002 | B1 |
6506178 | Schubart et al. | Jan 2003 | B1 |
6508765 | Suorsa et al. | Jan 2003 | B2 |
6508804 | Sarge et al. | Jan 2003 | B2 |
6508815 | Strul et al. | Jan 2003 | B1 |
6511478 | Burnside et al. | Jan 2003 | B1 |
6511496 | Huter et al. | Jan 2003 | B1 |
6511500 | Rahme | Jan 2003 | B1 |
6514236 | Stratienko | Feb 2003 | B1 |
6514245 | Williams et al. | Feb 2003 | B1 |
6514248 | Eggers et al. | Feb 2003 | B1 |
6517534 | McGovern et al. | Feb 2003 | B1 |
6517572 | Kugler et al. | Feb 2003 | B2 |
6522913 | Swanson et al. | Feb 2003 | B2 |
6522926 | Kieval et al. | Feb 2003 | B1 |
6524299 | Tran et al. | Feb 2003 | B1 |
6527765 | Kelman et al. | Mar 2003 | B2 |
6527769 | Langberg et al. | Mar 2003 | B2 |
6540761 | Houser | Apr 2003 | B2 |
6542781 | Koblish et al. | Apr 2003 | B1 |
6544780 | Wang | Apr 2003 | B1 |
6546272 | MacKinnon et al. | Apr 2003 | B1 |
6547788 | Maguire et al. | Apr 2003 | B1 |
6549800 | Atalar et al. | Apr 2003 | B1 |
6552796 | Magnin et al. | Apr 2003 | B2 |
6554780 | Sampson et al. | Apr 2003 | B1 |
6558381 | Ingle et al. | May 2003 | B2 |
6558382 | Jahns et al. | May 2003 | B2 |
6564096 | Mest | May 2003 | B2 |
6565582 | Gifford, III et al. | May 2003 | B2 |
6569109 | Sakurai et al. | May 2003 | B2 |
6569177 | Dillard et al. | May 2003 | B1 |
6570659 | Schmitt | May 2003 | B2 |
6572551 | Smith et al. | Jun 2003 | B1 |
6572612 | Stewart et al. | Jun 2003 | B2 |
6577902 | Laufer et al. | Jun 2003 | B1 |
6579308 | Jansen et al. | Jun 2003 | B1 |
6579311 | Makower | Jun 2003 | B1 |
6582423 | Thapliyal et al. | Jun 2003 | B1 |
6589238 | Edwards et al. | Jul 2003 | B2 |
6592526 | Lenker | Jul 2003 | B1 |
6592567 | Levin et al. | Jul 2003 | B1 |
6595959 | Stratienko | Jul 2003 | B1 |
6600956 | Maschino et al. | Jul 2003 | B2 |
6602242 | Fung | Aug 2003 | B1 |
6602246 | Joye et al. | Aug 2003 | B1 |
6605084 | Acker et al. | Aug 2003 | B2 |
6623452 | Chien et al. | Sep 2003 | B2 |
6623453 | Guibert et al. | Sep 2003 | B1 |
6632193 | Davison et al. | Oct 2003 | B1 |
6632196 | Houser | Oct 2003 | B1 |
6645223 | Boyle et al. | Nov 2003 | B2 |
6648854 | Patterson et al. | Nov 2003 | B1 |
6648878 | Lafontaine | Nov 2003 | B2 |
6648879 | Joye et al. | Nov 2003 | B2 |
6651672 | Roth | Nov 2003 | B2 |
6652513 | Panescu et al. | Nov 2003 | B2 |
6652515 | Maguire et al. | Nov 2003 | B1 |
6656136 | Weng et al. | Dec 2003 | B1 |
6658279 | Swanson et al. | Dec 2003 | B2 |
6659981 | Stewart et al. | Dec 2003 | B2 |
6666858 | Lafontaine | Dec 2003 | B2 |
6666863 | Wentzel et al. | Dec 2003 | B2 |
6669655 | Acker et al. | Dec 2003 | B1 |
6669692 | Nelson et al. | Dec 2003 | B1 |
6673040 | Samson et al. | Jan 2004 | B1 |
6673064 | Rentrop | Jan 2004 | B1 |
6673066 | Werneth | Jan 2004 | B2 |
6673090 | Root et al. | Jan 2004 | B2 |
6673101 | Fitzgerald et al. | Jan 2004 | B1 |
6673290 | Whayne et al. | Jan 2004 | B1 |
6676678 | Gifford, III et al. | Jan 2004 | B2 |
6679268 | Stevens et al. | Jan 2004 | B2 |
6681773 | Murphy et al. | Jan 2004 | B2 |
6682541 | Gifford, III et al. | Jan 2004 | B1 |
6684098 | Oshio et al. | Jan 2004 | B2 |
6685732 | Kramer | Feb 2004 | B2 |
6685733 | Dae et al. | Feb 2004 | B1 |
6689086 | Nita et al. | Feb 2004 | B1 |
6689148 | Sawhney et al. | Feb 2004 | B2 |
6690181 | Dowdeswell et al. | Feb 2004 | B1 |
6692490 | Edwards | Feb 2004 | B1 |
6695830 | Vigil et al. | Feb 2004 | B2 |
6695857 | Gifford, III et al. | Feb 2004 | B2 |
6699241 | Rappaport et al. | Mar 2004 | B2 |
6699257 | Gifford, III et al. | Mar 2004 | B2 |
6702748 | Nita et al. | Mar 2004 | B1 |
6702811 | Stewart et al. | Mar 2004 | B2 |
6706010 | Miki et al. | Mar 2004 | B1 |
6706011 | Murphy-Chutorian et al. | Mar 2004 | B1 |
6706037 | Zvuloni et al. | Mar 2004 | B2 |
6709431 | Lafontaine | Mar 2004 | B2 |
6711429 | Gilboa et al. | Mar 2004 | B1 |
6712815 | Sampson et al. | Mar 2004 | B2 |
6714822 | King et al. | Mar 2004 | B2 |
6716184 | Vaezy et al. | Apr 2004 | B2 |
6720350 | Kunz et al. | Apr 2004 | B2 |
6723043 | Kleeman et al. | Apr 2004 | B2 |
6723064 | Babaev | Apr 2004 | B2 |
6726677 | Flaherty et al. | Apr 2004 | B1 |
6736811 | Panescu et al. | May 2004 | B2 |
6743184 | Sampson et al. | Jun 2004 | B2 |
6746401 | Panescu | Jun 2004 | B2 |
6746464 | Makower | Jun 2004 | B1 |
6746474 | Saadat | Jun 2004 | B2 |
6748953 | Sherry et al. | Jun 2004 | B2 |
6749607 | Edwards et al. | Jun 2004 | B2 |
6752805 | Maguire et al. | Jun 2004 | B2 |
6760616 | Hoey et al. | Jul 2004 | B2 |
6763261 | Casscells, III et al. | Jul 2004 | B2 |
6764501 | Ganz | Jul 2004 | B2 |
6769433 | Zikorus et al. | Aug 2004 | B2 |
6770070 | Balbierz | Aug 2004 | B1 |
6771996 | Bowe et al. | Aug 2004 | B2 |
6773433 | Stewart et al. | Aug 2004 | B2 |
6786900 | Joye et al. | Sep 2004 | B2 |
6786901 | Joye et al. | Sep 2004 | B2 |
6786904 | Döscher et al. | Sep 2004 | B2 |
6788977 | Fenn et al. | Sep 2004 | B2 |
6790206 | Panescu | Sep 2004 | B2 |
6790222 | Kugler et al. | Sep 2004 | B2 |
6796981 | Wham et al. | Sep 2004 | B2 |
6797933 | Mendis et al. | Sep 2004 | B1 |
6797960 | Spartiotis et al. | Sep 2004 | B1 |
6800075 | Mische et al. | Oct 2004 | B2 |
6802857 | Walsh et al. | Oct 2004 | B1 |
6807444 | Tu et al. | Oct 2004 | B2 |
6811550 | Holland et al. | Nov 2004 | B2 |
6813520 | Truckai et al. | Nov 2004 | B2 |
6814730 | Li | Nov 2004 | B2 |
6814733 | Schwartz et al. | Nov 2004 | B2 |
6823205 | Jara | Nov 2004 | B1 |
6824516 | Batten et al. | Nov 2004 | B2 |
6827726 | Parodi | Dec 2004 | B2 |
6827926 | Robinson et al. | Dec 2004 | B2 |
6829497 | Mogul | Dec 2004 | B2 |
6830568 | Kesten et al. | Dec 2004 | B1 |
6837886 | Collins et al. | Jan 2005 | B2 |
6837888 | Ciarrocca et al. | Jan 2005 | B2 |
6845267 | Harrison | Jan 2005 | B2 |
6847848 | Sterzer | Jan 2005 | B2 |
6849073 | Hoey et al. | Feb 2005 | B2 |
6849075 | Bertolero et al. | Feb 2005 | B2 |
6853425 | Kim et al. | Feb 2005 | B2 |
6855123 | Nita | Feb 2005 | B2 |
6855143 | Davison | Feb 2005 | B2 |
6869431 | Maguire et al. | Mar 2005 | B2 |
6872183 | Sampson et al. | Mar 2005 | B2 |
6884260 | Kugler et al. | Apr 2005 | B2 |
6889694 | Hooven | May 2005 | B2 |
6893436 | Woodard et al. | May 2005 | B2 |
6895077 | Karellas et al. | May 2005 | B2 |
6895265 | Silver | May 2005 | B2 |
6898454 | Atalar et al. | May 2005 | B2 |
6899711 | Stewart et al. | May 2005 | B2 |
6899718 | Gifford, III et al. | May 2005 | B2 |
6905494 | Yon et al. | Jun 2005 | B2 |
6908462 | Joye et al. | Jun 2005 | B2 |
6908464 | Jenkins | Jun 2005 | B2 |
6909009 | Koridze | Jun 2005 | B2 |
6911026 | Hall et al. | Jun 2005 | B1 |
6915806 | Pacek et al. | Jul 2005 | B2 |
6923805 | LaFontaine et al. | Aug 2005 | B1 |
6923808 | Taimisto | Aug 2005 | B2 |
6926246 | Ginggen | Aug 2005 | B2 |
6926713 | Rioux et al. | Aug 2005 | B2 |
6926716 | Baker et al. | Aug 2005 | B2 |
6929009 | Makower et al. | Aug 2005 | B2 |
6929632 | Nita et al. | Aug 2005 | B2 |
6929639 | Lafontaine | Aug 2005 | B2 |
6932776 | Carr | Aug 2005 | B2 |
6936024 | Houser | Aug 2005 | B1 |
6936047 | Nasab et al. | Aug 2005 | B2 |
6942620 | Nita et al. | Sep 2005 | B2 |
6942657 | Sinofsky et al. | Sep 2005 | B2 |
6942677 | Nita et al. | Sep 2005 | B2 |
6942692 | Landau et al. | Sep 2005 | B2 |
6949097 | Stewart et al. | Sep 2005 | B2 |
6949121 | Laguna | Sep 2005 | B1 |
6952615 | Satake | Oct 2005 | B2 |
6953425 | Brister | Oct 2005 | B2 |
6955174 | Joye et al. | Oct 2005 | B2 |
6955175 | Stevens et al. | Oct 2005 | B2 |
6959711 | Murphy et al. | Nov 2005 | B2 |
6960207 | Vanney et al. | Nov 2005 | B2 |
6962584 | Stone et al. | Nov 2005 | B1 |
6964660 | Maguire et al. | Nov 2005 | B2 |
6966908 | Maguire et al. | Nov 2005 | B2 |
6972015 | Joye et al. | Dec 2005 | B2 |
6972024 | Kilpatrick et al. | Dec 2005 | B1 |
6974456 | Edwards et al. | Dec 2005 | B2 |
6978174 | Gelfand et al. | Dec 2005 | B2 |
6979329 | Burnside et al. | Dec 2005 | B2 |
6979420 | Weber | Dec 2005 | B2 |
6984238 | Gifford, III et al. | Jan 2006 | B2 |
6985774 | Kieval et al. | Jan 2006 | B2 |
6986739 | Warren et al. | Jan 2006 | B2 |
6989009 | Lafontaine | Jan 2006 | B2 |
6989010 | Francischelli et al. | Jan 2006 | B2 |
6991617 | Hektner et al. | Jan 2006 | B2 |
7001378 | Yon et al. | Feb 2006 | B2 |
7006858 | Silver et al. | Feb 2006 | B2 |
7022105 | Edwards | Apr 2006 | B1 |
7022120 | Lafontaine | Apr 2006 | B2 |
7025767 | Schaefer et al. | Apr 2006 | B2 |
7033322 | Silver | Apr 2006 | B2 |
7033372 | Cahalan | Apr 2006 | B1 |
7041098 | Farley et al. | May 2006 | B2 |
7050848 | Hoey et al. | May 2006 | B2 |
7063670 | Sampson et al. | Jun 2006 | B2 |
7063679 | Maguire et al. | Jun 2006 | B2 |
7063719 | Jansen et al. | Jun 2006 | B2 |
7066895 | Podany | Jun 2006 | B2 |
7066900 | Botto et al. | Jun 2006 | B2 |
7066904 | Rosenthal et al. | Jun 2006 | B2 |
7072720 | Puskas | Jul 2006 | B2 |
7074217 | Strul et al. | Jul 2006 | B2 |
7081112 | Joye et al. | Jul 2006 | B2 |
7081114 | Rashidi | Jul 2006 | B2 |
7083614 | Fjield et al. | Aug 2006 | B2 |
7084276 | Vu et al. | Aug 2006 | B2 |
7087026 | Callister et al. | Aug 2006 | B2 |
7087051 | Bourne et al. | Aug 2006 | B2 |
7087052 | Sampson et al. | Aug 2006 | B2 |
7087053 | Vanney | Aug 2006 | B2 |
7089065 | Westlund et al. | Aug 2006 | B2 |
7097641 | Arless et al. | Aug 2006 | B1 |
7100614 | Stevens et al. | Sep 2006 | B2 |
7101368 | Lafontaine | Sep 2006 | B2 |
7104983 | Grasso, III et al. | Sep 2006 | B2 |
7104987 | Biggs et al. | Sep 2006 | B2 |
7108715 | Lawrence-Brown et al. | Sep 2006 | B2 |
7112196 | Brosch et al. | Sep 2006 | B2 |
7112198 | Satake | Sep 2006 | B2 |
7112211 | Gifford, III et al. | Sep 2006 | B2 |
7122019 | Kesten et al. | Oct 2006 | B1 |
7122033 | Wood | Oct 2006 | B2 |
7134438 | Makower et al. | Nov 2006 | B2 |
7137963 | Nita et al. | Nov 2006 | B2 |
7137980 | Buysse et al. | Nov 2006 | B2 |
7153315 | Miller | Dec 2006 | B2 |
7155271 | Halperin et al. | Dec 2006 | B2 |
7157491 | Mewshaw et al. | Jan 2007 | B2 |
7157492 | Mewshaw et al. | Jan 2007 | B2 |
7158832 | Kieval et al. | Jan 2007 | B2 |
7160296 | Pearson et al. | Jan 2007 | B2 |
7162303 | Levin et al. | Jan 2007 | B2 |
7165551 | Edwards et al. | Jan 2007 | B2 |
7169144 | Hoey et al. | Jan 2007 | B2 |
7172589 | Lafontaine | Feb 2007 | B2 |
7172610 | Heitzmann et al. | Feb 2007 | B2 |
7181261 | Silver et al. | Feb 2007 | B2 |
7184811 | Phan et al. | Feb 2007 | B2 |
7184827 | Edwards | Feb 2007 | B1 |
7189227 | Lafontaine | Mar 2007 | B2 |
7192427 | Chapelon et al. | Mar 2007 | B2 |
7192586 | Bander | Mar 2007 | B2 |
7197354 | Sobe | Mar 2007 | B2 |
7198632 | Lim et al. | Apr 2007 | B2 |
7200445 | Dalbec et al. | Apr 2007 | B1 |
7201749 | Govari et al. | Apr 2007 | B2 |
7203537 | Mower | Apr 2007 | B2 |
7214234 | Rapacki et al. | May 2007 | B2 |
7220233 | Nita et al. | May 2007 | B2 |
7220239 | Wilson et al. | May 2007 | B2 |
7220257 | Lafontaine | May 2007 | B1 |
7220270 | Sawhney et al. | May 2007 | B2 |
7232458 | Saadat | Jun 2007 | B2 |
7232459 | Greenberg et al. | Jun 2007 | B2 |
7238184 | Megerman et al. | Jul 2007 | B2 |
7241273 | Maguire et al. | Jul 2007 | B2 |
7241736 | Hunter et al. | Jul 2007 | B2 |
7247141 | Makin et al. | Jul 2007 | B2 |
7250041 | Chiu et al. | Jul 2007 | B2 |
7250440 | Mewshaw et al. | Jul 2007 | B2 |
7252664 | Nasab et al. | Aug 2007 | B2 |
7252679 | Fischell et al. | Aug 2007 | B2 |
7264619 | Venturelli | Sep 2007 | B2 |
7279600 | Mewshaw et al. | Oct 2007 | B2 |
7280863 | Shachar | Oct 2007 | B2 |
7282213 | Schroeder et al. | Oct 2007 | B2 |
7285119 | Stewart et al. | Oct 2007 | B2 |
7285120 | Im et al. | Oct 2007 | B2 |
7288089 | Yon et al. | Oct 2007 | B2 |
7288096 | Chin | Oct 2007 | B2 |
7291146 | Steinke et al. | Nov 2007 | B2 |
7293562 | Malecki et al. | Nov 2007 | B2 |
7294125 | Phalen et al. | Nov 2007 | B2 |
7294126 | Sampson et al. | Nov 2007 | B2 |
7294127 | Leung et al. | Nov 2007 | B2 |
7297131 | Nita | Nov 2007 | B2 |
7297475 | Koiwai et al. | Nov 2007 | B2 |
7300433 | Lane et al. | Nov 2007 | B2 |
7301108 | Egitto et al. | Nov 2007 | B2 |
7310150 | Guillermo et al. | Dec 2007 | B2 |
7313430 | Urquhart et al. | Dec 2007 | B2 |
7314483 | Landau et al. | Jan 2008 | B2 |
7317077 | Averback et al. | Jan 2008 | B2 |
7323006 | Andreas et al. | Jan 2008 | B2 |
7326206 | Paul et al. | Feb 2008 | B2 |
7326226 | Root et al. | Feb 2008 | B2 |
7326235 | Edwards | Feb 2008 | B2 |
7326237 | DePalma et al. | Feb 2008 | B2 |
7329236 | Kesten et al. | Feb 2008 | B2 |
7335180 | Nita et al. | Feb 2008 | B2 |
7335192 | Keren et al. | Feb 2008 | B2 |
7338467 | Lutter | Mar 2008 | B2 |
7341570 | Keren et al. | Mar 2008 | B2 |
7343195 | Strommer et al. | Mar 2008 | B2 |
7347857 | Anderson et al. | Mar 2008 | B2 |
7348003 | Salcedo et al. | Mar 2008 | B2 |
7352593 | Zeng et al. | Apr 2008 | B2 |
7354927 | Vu | Apr 2008 | B2 |
7359732 | Kim et al. | Apr 2008 | B2 |
7361341 | Salcedo et al. | Apr 2008 | B2 |
7364566 | Elkins et al. | Apr 2008 | B2 |
7367970 | Govari et al. | May 2008 | B2 |
7367975 | Malecki et al. | May 2008 | B2 |
7371231 | Rioux et al. | May 2008 | B2 |
7371235 | Thompson | May 2008 | B2 |
7387126 | Cox et al. | Jun 2008 | B2 |
7393338 | Nita | Jul 2008 | B2 |
7396355 | Goldman et al. | Jul 2008 | B2 |
7402151 | Rosenman et al. | Jul 2008 | B2 |
7402312 | Rosen et al. | Jul 2008 | B2 |
7404824 | Webler et al. | Jul 2008 | B1 |
7406970 | Zikorus et al. | Aug 2008 | B2 |
7407502 | Strul et al. | Aug 2008 | B2 |
7407506 | Makower | Aug 2008 | B2 |
7407671 | McBride et al. | Aug 2008 | B2 |
7408021 | Averback et al. | Aug 2008 | B2 |
7410486 | Fuimaono et al. | Aug 2008 | B2 |
7413556 | Zhang et al. | Aug 2008 | B2 |
7425212 | Danek et al. | Sep 2008 | B1 |
7426409 | Casscells, III et al. | Sep 2008 | B2 |
7435248 | Taimisto et al. | Oct 2008 | B2 |
7447453 | Kim et al. | Nov 2008 | B2 |
7449018 | Kramer | Nov 2008 | B2 |
7452538 | Ni et al. | Nov 2008 | B2 |
7473890 | Grier et al. | Jan 2009 | B2 |
7476384 | Ni et al. | Jan 2009 | B2 |
7479157 | Weber et al. | Jan 2009 | B2 |
7481803 | Kesten et al. | Jan 2009 | B2 |
7485104 | Kieval | Feb 2009 | B2 |
7486805 | Krattiger | Feb 2009 | B2 |
7487780 | Hooven | Feb 2009 | B2 |
7493154 | Bonner et al. | Feb 2009 | B2 |
7494485 | Beck et al. | Feb 2009 | B2 |
7494486 | Mische et al. | Feb 2009 | B2 |
7494488 | Weber | Feb 2009 | B2 |
7494661 | Sanders | Feb 2009 | B2 |
7495439 | Wiggins | Feb 2009 | B2 |
7497858 | Chapelon et al. | Mar 2009 | B2 |
7499745 | Littrup et al. | Mar 2009 | B2 |
7500985 | Saadat | Mar 2009 | B2 |
7505812 | Eggers et al. | Mar 2009 | B1 |
7505816 | Schmeling et al. | Mar 2009 | B2 |
7507233 | Littrup et al. | Mar 2009 | B2 |
7507235 | Keogh et al. | Mar 2009 | B2 |
7511494 | Wedeen | Mar 2009 | B2 |
7512445 | Truckai et al. | Mar 2009 | B2 |
7527643 | Case et al. | May 2009 | B2 |
7529589 | Williams et al. | May 2009 | B2 |
7540852 | Nita et al. | Jun 2009 | B2 |
7540870 | Babaev | Jun 2009 | B2 |
RE40863 | Tay et al. | Jul 2009 | E |
7556624 | Laufer et al. | Jul 2009 | B2 |
7558625 | Levin et al. | Jul 2009 | B2 |
7563247 | Maguire et al. | Jul 2009 | B2 |
7566319 | McAuley et al. | Jul 2009 | B2 |
7569052 | Phan et al. | Aug 2009 | B2 |
7582111 | Krolik et al. | Sep 2009 | B2 |
7584004 | Caparso et al. | Sep 2009 | B2 |
7585835 | Hill et al. | Sep 2009 | B2 |
7591996 | Hwang et al. | Sep 2009 | B2 |
7597704 | Frazier et al. | Oct 2009 | B2 |
7598228 | Hattori et al. | Oct 2009 | B2 |
7599730 | Hunter et al. | Oct 2009 | B2 |
7603166 | Casscells, III et al. | Oct 2009 | B2 |
7604608 | Nita et al. | Oct 2009 | B2 |
7604633 | Truckai et al. | Oct 2009 | B2 |
7615015 | Coleman | Nov 2009 | B2 |
7615072 | Rust et al. | Nov 2009 | B2 |
7617005 | Demarais et al. | Nov 2009 | B2 |
7620451 | Demarais et al. | Nov 2009 | B2 |
7621902 | Nita et al. | Nov 2009 | B2 |
7621929 | Nita et al. | Nov 2009 | B2 |
7626015 | Feinstein et al. | Dec 2009 | B2 |
7626235 | Kinoshita | Dec 2009 | B2 |
7632268 | Edwards et al. | Dec 2009 | B2 |
7632845 | Vu et al. | Dec 2009 | B2 |
7635383 | Gumm | Dec 2009 | B2 |
7640046 | Pastore et al. | Dec 2009 | B2 |
7641633 | Laufer et al. | Jan 2010 | B2 |
7641679 | Joye et al. | Jan 2010 | B2 |
7646544 | Batchko et al. | Jan 2010 | B2 |
7647115 | Levin et al. | Jan 2010 | B2 |
7653438 | Deem et al. | Jan 2010 | B2 |
7655006 | Sauvageau et al. | Feb 2010 | B2 |
7662114 | Seip et al. | Feb 2010 | B2 |
7664548 | Amurthur et al. | Feb 2010 | B2 |
7670279 | Gertner | Mar 2010 | B2 |
7670335 | Keidar | Mar 2010 | B2 |
7671084 | Mewshaw et al. | Mar 2010 | B2 |
7678104 | Keidar | Mar 2010 | B2 |
7678106 | Lee | Mar 2010 | B2 |
7678108 | Chrisitian et al. | Mar 2010 | B2 |
7691080 | Seward et al. | Apr 2010 | B2 |
7699809 | Urmey | Apr 2010 | B2 |
7706882 | Francischelli et al. | Apr 2010 | B2 |
7715912 | Rezai et al. | May 2010 | B2 |
7717853 | Nita | May 2010 | B2 |
7717909 | Strul et al. | May 2010 | B2 |
7717948 | Demarais et al. | May 2010 | B2 |
7722539 | Carter et al. | May 2010 | B2 |
7725157 | Dumoulin et al. | May 2010 | B2 |
7727178 | Wilson et al. | Jun 2010 | B2 |
7736317 | Stephens et al. | Jun 2010 | B2 |
7736360 | Mody et al. | Jun 2010 | B2 |
7736362 | Eberl et al. | Jun 2010 | B2 |
7738952 | Yun et al. | Jun 2010 | B2 |
7740629 | Anderson et al. | Jun 2010 | B2 |
7741299 | Feinstein et al. | Jun 2010 | B2 |
7742795 | Stone et al. | Jun 2010 | B2 |
7744594 | Yamazaki et al. | Jun 2010 | B2 |
7753907 | DiMatteo et al. | Jul 2010 | B2 |
7756583 | Demarais et al. | Jul 2010 | B2 |
7758510 | Nita et al. | Jul 2010 | B2 |
7758520 | Griffin et al. | Jul 2010 | B2 |
7759315 | Cuzzocrea et al. | Jul 2010 | B2 |
7766833 | Lee et al. | Aug 2010 | B2 |
7766878 | Tremaglio, Jr. et al. | Aug 2010 | B2 |
7766892 | Keren et al. | Aug 2010 | B2 |
7767844 | Lee et al. | Aug 2010 | B2 |
7769427 | Shachar | Aug 2010 | B2 |
7771372 | Wilson | Aug 2010 | B2 |
7771421 | Stewart et al. | Aug 2010 | B2 |
7776967 | Perry et al. | Aug 2010 | B2 |
7777486 | Hargreaves et al. | Aug 2010 | B2 |
7780660 | Bourne et al. | Aug 2010 | B2 |
7789876 | Zikorus et al. | Sep 2010 | B2 |
7792568 | Zhong et al. | Sep 2010 | B2 |
7799021 | Leung et al. | Sep 2010 | B2 |
7803168 | Gifford et al. | Sep 2010 | B2 |
7806871 | Li et al. | Oct 2010 | B2 |
7811265 | Hering et al. | Oct 2010 | B2 |
7811281 | Rentrop | Oct 2010 | B1 |
7811313 | Mon et al. | Oct 2010 | B2 |
7816511 | Kawashima et al. | Oct 2010 | B2 |
7818053 | Kassab | Oct 2010 | B2 |
7819866 | Bednarek | Oct 2010 | B2 |
7822460 | Halperin et al. | Oct 2010 | B2 |
7828837 | Khoury | Nov 2010 | B2 |
7832407 | Gertner | Nov 2010 | B2 |
7833220 | Mon et al. | Nov 2010 | B2 |
7837676 | Sinelnikov et al. | Nov 2010 | B2 |
7837720 | Mon | Nov 2010 | B2 |
7841978 | Gertner | Nov 2010 | B2 |
7846157 | Kozel | Dec 2010 | B2 |
7846160 | Payne et al. | Dec 2010 | B2 |
7846172 | Makower | Dec 2010 | B2 |
7849860 | Makower et al. | Dec 2010 | B2 |
7850685 | Kunis et al. | Dec 2010 | B2 |
7853331 | Kaplan et al. | Dec 2010 | B2 |
7853333 | Demarais | Dec 2010 | B2 |
7854734 | Biggs et al. | Dec 2010 | B2 |
7857756 | Warren et al. | Dec 2010 | B2 |
7862565 | Eder et al. | Jan 2011 | B2 |
7863897 | Slocum, Jr. et al. | Jan 2011 | B2 |
7869854 | Shachar et al. | Jan 2011 | B2 |
7873417 | Demarais et al. | Jan 2011 | B2 |
7887538 | Bleich et al. | Feb 2011 | B2 |
7894905 | Pless et al. | Feb 2011 | B2 |
7896873 | Hiller et al. | Mar 2011 | B2 |
7901400 | Wham et al. | Mar 2011 | B2 |
7901402 | Jones et al. | Mar 2011 | B2 |
7901420 | Dunn | Mar 2011 | B2 |
7905862 | Sampson | Mar 2011 | B2 |
7918850 | Govari et al. | Apr 2011 | B2 |
7927370 | Webler et al. | Apr 2011 | B2 |
7937143 | Demarais et al. | May 2011 | B2 |
7938830 | Saadat et al. | May 2011 | B2 |
7942874 | Eder et al. | May 2011 | B2 |
7942928 | Webler et al. | May 2011 | B2 |
7946976 | Gertner | May 2011 | B2 |
7949400 | Keval et al. | May 2011 | B2 |
7950397 | Thapliyal et al. | May 2011 | B2 |
7955293 | Nita et al. | Jun 2011 | B2 |
7956613 | Wald | Jun 2011 | B2 |
7959627 | Utley et al. | Jun 2011 | B2 |
7962854 | Vance et al. | Jun 2011 | B2 |
7967782 | Laufer et al. | Jun 2011 | B2 |
7967808 | Fitzgerald et al. | Jun 2011 | B2 |
7972327 | Eberl et al. | Jul 2011 | B2 |
7972330 | Alejandro et al. | Jul 2011 | B2 |
7983751 | Zdeblick et al. | Jul 2011 | B2 |
8001976 | Gertner | Aug 2011 | B2 |
8007440 | Magnin et al. | Aug 2011 | B2 |
8012147 | Lafontaine | Sep 2011 | B2 |
8019435 | Hastings et al. | Sep 2011 | B2 |
8021362 | Deem et al. | Sep 2011 | B2 |
8021413 | Dierking et al. | Sep 2011 | B2 |
8025661 | Arnold et al. | Sep 2011 | B2 |
8027718 | Spinner et al. | Sep 2011 | B2 |
8031927 | Karl et al. | Oct 2011 | B2 |
8033284 | Porter et al. | Oct 2011 | B2 |
8048144 | Thistle et al. | Nov 2011 | B2 |
8052636 | Moll et al. | Nov 2011 | B2 |
8052700 | Dunn | Nov 2011 | B2 |
8062289 | Babaev | Nov 2011 | B2 |
8075580 | Makower | Dec 2011 | B2 |
8080006 | Lafontaine et al. | Dec 2011 | B2 |
8088127 | Mayse et al. | Jan 2012 | B2 |
8116883 | Williams et al. | Feb 2012 | B2 |
8119183 | O'Donoghue et al. | Feb 2012 | B2 |
8120518 | Jang et al. | Feb 2012 | B2 |
8123741 | Marrouche et al. | Feb 2012 | B2 |
8128617 | Bencini et al. | Mar 2012 | B2 |
8131371 | Demarals et al. | Mar 2012 | B2 |
8131372 | Levin et al. | Mar 2012 | B2 |
8131382 | Asada | Mar 2012 | B2 |
8137274 | Weng et al. | Mar 2012 | B2 |
8140170 | Rezai et al. | Mar 2012 | B2 |
8143316 | Ueno | Mar 2012 | B2 |
8145316 | Deem et al. | Mar 2012 | B2 |
8145317 | Demarais et al. | Mar 2012 | B2 |
8150518 | Levin et al. | Apr 2012 | B2 |
8150519 | Demarais et al. | Apr 2012 | B2 |
8150520 | Demarais et al. | Apr 2012 | B2 |
8152830 | Gumm | Apr 2012 | B2 |
8162933 | Francischelli et al. | Apr 2012 | B2 |
8175711 | Demarais et al. | May 2012 | B2 |
8187261 | Watson | May 2012 | B2 |
8190238 | Moll et al. | May 2012 | B2 |
8192053 | Owen et al. | Jun 2012 | B2 |
8198611 | LaFontaine et al. | Jun 2012 | B2 |
8214056 | Hoffer et al. | Jul 2012 | B2 |
8221407 | Phan et al. | Jul 2012 | B2 |
8226637 | Satake | Jul 2012 | B2 |
8231617 | Satake | Jul 2012 | B2 |
8241217 | Chiang et al. | Aug 2012 | B2 |
8251992 | Utley et al. | Aug 2012 | B2 |
8257413 | Danek et al. | Sep 2012 | B2 |
8257724 | Cromack et al. | Sep 2012 | B2 |
8257725 | Cromack et al. | Sep 2012 | B2 |
8260397 | Ruff et al. | Sep 2012 | B2 |
8263104 | Ho et al. | Sep 2012 | B2 |
8273023 | Razavi | Sep 2012 | B2 |
8277379 | Lau et al. | Oct 2012 | B2 |
8287524 | Siegel | Oct 2012 | B2 |
8287532 | Carroll et al. | Oct 2012 | B2 |
8292881 | Brannan et al. | Oct 2012 | B2 |
8293703 | Averback et al. | Oct 2012 | B2 |
8295902 | Salahieh et al. | Oct 2012 | B2 |
8295912 | Gertner | Oct 2012 | B2 |
8308722 | Ormsby et al. | Nov 2012 | B2 |
8317776 | Ferren et al. | Nov 2012 | B2 |
8317810 | Stangenes et al. | Nov 2012 | B2 |
8323261 | Kugler et al. | Dec 2012 | B2 |
8329179 | Ni et al. | Dec 2012 | B2 |
8336705 | Okahisa | Dec 2012 | B2 |
8343031 | Gertner | Jan 2013 | B2 |
8343145 | Brannan | Jan 2013 | B2 |
8347891 | Demarais et al. | Jan 2013 | B2 |
8353945 | Andreas et al. | Jan 2013 | B2 |
8364237 | Stone et al. | Jan 2013 | B2 |
8366615 | Razavi | Feb 2013 | B2 |
8382697 | Brenneman et al. | Feb 2013 | B2 |
8388680 | Starksen et al. | Mar 2013 | B2 |
8396548 | Perry et al. | Mar 2013 | B2 |
8398629 | Thistle | Mar 2013 | B2 |
8401667 | Gustus et al. | Mar 2013 | B2 |
8403881 | Ferren et al. | Mar 2013 | B2 |
8406877 | Smith et al. | Mar 2013 | B2 |
8409172 | Moll et al. | Apr 2013 | B2 |
8409193 | Young et al. | Apr 2013 | B2 |
8409195 | Young | Apr 2013 | B2 |
8418362 | Zerfas et al. | Apr 2013 | B2 |
8452988 | Wang | May 2013 | B2 |
8454594 | Demarais et al. | Jun 2013 | B2 |
8460358 | Andreas et al. | Jun 2013 | B2 |
8465452 | Kassab | Jun 2013 | B2 |
8469919 | Ingle et al. | Jun 2013 | B2 |
8473067 | Hastings et al. | Jun 2013 | B2 |
8480663 | Ingle et al. | Jul 2013 | B2 |
8485992 | Griffin et al. | Jul 2013 | B2 |
8486060 | Kotmel et al. | Jul 2013 | B2 |
8486063 | Werneth et al. | Jul 2013 | B2 |
8488591 | Miali et al. | Jul 2013 | B2 |
20010007070 | Stewart et al. | Jul 2001 | A1 |
20010039419 | Francischelli et al. | Nov 2001 | A1 |
20020022864 | Mahvi et al. | Feb 2002 | A1 |
20020042639 | Murphy-Chutorian et al. | Apr 2002 | A1 |
20020045811 | Kittrell et al. | Apr 2002 | A1 |
20020045890 | Celliers et al. | Apr 2002 | A1 |
20020062146 | Makower et al. | May 2002 | A1 |
20020065542 | Lax et al. | May 2002 | A1 |
20020087151 | Mody et al. | Jul 2002 | A1 |
20020095197 | Lardo et al. | Jul 2002 | A1 |
20020107536 | Hussein | Aug 2002 | A1 |
20020147480 | Mamayek | Oct 2002 | A1 |
20020169444 | Mest et al. | Nov 2002 | A1 |
20020198520 | Coen et al. | Dec 2002 | A1 |
20030065317 | Rudie et al. | Apr 2003 | A1 |
20030092995 | Thompson | May 2003 | A1 |
20030139689 | Shturman et al. | Jul 2003 | A1 |
20030195501 | Sherman et al. | Oct 2003 | A1 |
20030199747 | Michlitsch et al. | Oct 2003 | A1 |
20040010118 | Zerhusen et al. | Jan 2004 | A1 |
20040019348 | Stevens et al. | Jan 2004 | A1 |
20040024371 | Plicchi et al. | Feb 2004 | A1 |
20040043030 | Griffiths et al. | Mar 2004 | A1 |
20040064090 | Keren et al. | Apr 2004 | A1 |
20040073206 | Foley et al. | Apr 2004 | A1 |
20040088002 | Boyle et al. | May 2004 | A1 |
20040093055 | Bartorelli et al. | May 2004 | A1 |
20040106871 | Hunyor et al. | Jun 2004 | A1 |
20040117032 | Roth | Jun 2004 | A1 |
20040147915 | Hasebe | Jul 2004 | A1 |
20040162555 | Farley et al. | Aug 2004 | A1 |
20040167506 | Chen | Aug 2004 | A1 |
20040186356 | O'Malley et al. | Sep 2004 | A1 |
20040187875 | He et al. | Sep 2004 | A1 |
20040193211 | Voegele et al. | Sep 2004 | A1 |
20040220556 | Cooper et al. | Nov 2004 | A1 |
20040243022 | Carney et al. | Dec 2004 | A1 |
20040253304 | Gross et al. | Dec 2004 | A1 |
20040267250 | Yon et al. | Dec 2004 | A1 |
20050010095 | Stewart et al. | Jan 2005 | A1 |
20050015125 | Mioduski et al. | Jan 2005 | A1 |
20050080374 | Esch et al. | Apr 2005 | A1 |
20050129616 | Salcedo et al. | Jun 2005 | A1 |
20050137180 | Robinson et al. | Jun 2005 | A1 |
20050143817 | Hunter et al. | Jun 2005 | A1 |
20050148842 | Wang et al. | Jul 2005 | A1 |
20050149069 | Bertolero et al. | Jul 2005 | A1 |
20050149080 | Hunter et al. | Jul 2005 | A1 |
20050149158 | Hunter et al. | Jul 2005 | A1 |
20050149173 | Hunter et al. | Jul 2005 | A1 |
20050149175 | Hunter et al. | Jul 2005 | A1 |
20050154277 | Tang et al. | Jul 2005 | A1 |
20050154445 | Hunter et al. | Jul 2005 | A1 |
20050154453 | Hunter et al. | Jul 2005 | A1 |
20050154454 | Hunter et al. | Jul 2005 | A1 |
20050165389 | Swain et al. | Jul 2005 | A1 |
20050165391 | Maguire et al. | Jul 2005 | A1 |
20050165467 | Hunter et al. | Jul 2005 | A1 |
20050165488 | Hunter et al. | Jul 2005 | A1 |
20050175661 | Hunter et al. | Aug 2005 | A1 |
20050175662 | Hunter et al. | Aug 2005 | A1 |
20050175663 | Hunter et al. | Aug 2005 | A1 |
20050177103 | Hunter et al. | Aug 2005 | A1 |
20050177225 | Hunter et al. | Aug 2005 | A1 |
20050181004 | Hunter et al. | Aug 2005 | A1 |
20050181008 | Hunter et al. | Aug 2005 | A1 |
20050181011 | Hunter et al. | Aug 2005 | A1 |
20050181977 | Hunter et al. | Aug 2005 | A1 |
20050182479 | Bonsignore et al. | Aug 2005 | A1 |
20050183728 | Hunter et al. | Aug 2005 | A1 |
20050186242 | Hunter et al. | Aug 2005 | A1 |
20050186243 | Hunter et al. | Aug 2005 | A1 |
20050191331 | Hunter et al. | Sep 2005 | A1 |
20050203410 | Jenkins | Sep 2005 | A1 |
20050209587 | Joye et al. | Sep 2005 | A1 |
20050214205 | Salcedo et al. | Sep 2005 | A1 |
20050214207 | Salcedo et al. | Sep 2005 | A1 |
20050214208 | Salcedo et al. | Sep 2005 | A1 |
20050214209 | Salcedo et al. | Sep 2005 | A1 |
20050214210 | Salcedo et al. | Sep 2005 | A1 |
20050214268 | Cavanagh et al. | Sep 2005 | A1 |
20050228286 | Messerly et al. | Oct 2005 | A1 |
20050228415 | Gertner | Oct 2005 | A1 |
20050228460 | Levin et al. | Oct 2005 | A1 |
20050232921 | Rosen et al. | Oct 2005 | A1 |
20050234312 | Suzuki et al. | Oct 2005 | A1 |
20050245862 | Seward | Nov 2005 | A1 |
20050251116 | Steinke et al. | Nov 2005 | A1 |
20050252553 | Ginggen | Nov 2005 | A1 |
20050256398 | Hastings et al. | Nov 2005 | A1 |
20050267556 | Shuros et al. | Dec 2005 | A1 |
20050288730 | Deem | Dec 2005 | A1 |
20060004323 | Chang et al. | Jan 2006 | A1 |
20060018949 | Ammon et al. | Jan 2006 | A1 |
20060024564 | Manclaw | Feb 2006 | A1 |
20060025765 | Landman et al. | Feb 2006 | A1 |
20060062786 | Salcedo et al. | Mar 2006 | A1 |
20060083194 | Dhrimaj et al. | Apr 2006 | A1 |
20060089637 | Werneth et al. | Apr 2006 | A1 |
20060089638 | Carmel et al. | Apr 2006 | A1 |
20060095096 | DeBenedictis et al. | May 2006 | A1 |
20060106375 | Werneth et al. | May 2006 | A1 |
20060142790 | Gertner | Jun 2006 | A1 |
20060147492 | Hunter et al. | Jul 2006 | A1 |
20060167106 | Zhang et al. | Jul 2006 | A1 |
20060167498 | DiLorenzo | Jul 2006 | A1 |
20060171895 | Bucay-Couto | Aug 2006 | A1 |
20060184221 | Stewart et al. | Aug 2006 | A1 |
20060195139 | Gertner | Aug 2006 | A1 |
20060206150 | Demarais et al. | Sep 2006 | A1 |
20060224153 | Fischell et al. | Oct 2006 | A1 |
20060239921 | Mangat et al. | Oct 2006 | A1 |
20060240070 | Cromack et al. | Oct 2006 | A1 |
20060247266 | Yamada et al. | Nov 2006 | A1 |
20060247760 | Ganesan et al. | Nov 2006 | A1 |
20060263393 | Demopulos et al. | Nov 2006 | A1 |
20060269555 | Salcedo et al. | Nov 2006 | A1 |
20060271111 | Demarais et al. | Nov 2006 | A1 |
20060287644 | Inganas et al. | Dec 2006 | A1 |
20070016184 | Cropper et al. | Jan 2007 | A1 |
20070016274 | Boveja et al. | Jan 2007 | A1 |
20070027390 | Maschke et al. | Feb 2007 | A1 |
20070043077 | Mewshaw et al. | Feb 2007 | A1 |
20070043409 | Brian et al. | Feb 2007 | A1 |
20070049924 | Rahn | Mar 2007 | A1 |
20070066972 | Ormsby et al. | Mar 2007 | A1 |
20070073151 | Lee | Mar 2007 | A1 |
20070093710 | Maschke | Apr 2007 | A1 |
20070100405 | Thompson et al. | May 2007 | A1 |
20070106247 | Burnett et al. | May 2007 | A1 |
20070112327 | Yun et al. | May 2007 | A1 |
20070118107 | Francischelli et al. | May 2007 | A1 |
20070129760 | Demarais et al. | Jun 2007 | A1 |
20070129761 | Demarais et al. | Jun 2007 | A1 |
20070135875 | Demarais et al. | Jun 2007 | A1 |
20070149963 | Matsukuma et al. | Jun 2007 | A1 |
20070162109 | Davila et al. | Jul 2007 | A1 |
20070173805 | Weinberg et al. | Jul 2007 | A1 |
20070179496 | Swoyer et al. | Aug 2007 | A1 |
20070203480 | Mody et al. | Aug 2007 | A1 |
20070207186 | Scanlon et al. | Sep 2007 | A1 |
20070208134 | Hunter et al. | Sep 2007 | A1 |
20070208210 | Gelfand et al. | Sep 2007 | A1 |
20070208256 | Marilla | Sep 2007 | A1 |
20070208301 | Evard et al. | Sep 2007 | A1 |
20070219576 | Cangialosi | Sep 2007 | A1 |
20070225781 | Saadat et al. | Sep 2007 | A1 |
20070233170 | Gertner | Oct 2007 | A1 |
20070239062 | Chopra et al. | Oct 2007 | A1 |
20070248639 | Demopulos et al. | Oct 2007 | A1 |
20070249703 | Mewshaw et al. | Oct 2007 | A1 |
20070254833 | Hunter et al. | Nov 2007 | A1 |
20070265687 | Deem et al. | Nov 2007 | A1 |
20070278103 | Hoerr et al. | Dec 2007 | A1 |
20070282302 | Wachsman et al. | Dec 2007 | A1 |
20070292411 | Salcedo et al. | Dec 2007 | A1 |
20070293782 | Marino | Dec 2007 | A1 |
20070293923 | Soltis et al. | Dec 2007 | A1 |
20070299043 | Hunter et al. | Dec 2007 | A1 |
20080004673 | Rossing et al. | Jan 2008 | A1 |
20080009927 | Vilims | Jan 2008 | A1 |
20080015501 | Gertner | Jan 2008 | A1 |
20080021408 | Jacobsen et al. | Jan 2008 | A1 |
20080033049 | Mewshaw | Feb 2008 | A1 |
20080039746 | Hissong et al. | Feb 2008 | A1 |
20080039830 | Munger et al. | Feb 2008 | A1 |
20080051454 | Wang | Feb 2008 | A1 |
20080064957 | Spence | Mar 2008 | A1 |
20080071269 | Hilario et al. | Mar 2008 | A1 |
20080071306 | Gertner | Mar 2008 | A1 |
20080082109 | Moll et al. | Apr 2008 | A1 |
20080086072 | Bonutti et al. | Apr 2008 | A1 |
20080091193 | Kauphusman et al. | Apr 2008 | A1 |
20080097251 | Babaev | Apr 2008 | A1 |
20080097426 | Root et al. | Apr 2008 | A1 |
20080108867 | Zhou | May 2008 | A1 |
20080119879 | Brenneman et al. | May 2008 | A1 |
20080125772 | Stone et al. | May 2008 | A1 |
20080132450 | Lee et al. | Jun 2008 | A1 |
20080140002 | Ramzipoor et al. | Jun 2008 | A1 |
20080147002 | Gertner | Jun 2008 | A1 |
20080161662 | Golijanin et al. | Jul 2008 | A1 |
20080161717 | Gertner | Jul 2008 | A1 |
20080161801 | Steinke et al. | Jul 2008 | A1 |
20080171974 | Lafontaine et al. | Jul 2008 | A1 |
20080172035 | Starksen et al. | Jul 2008 | A1 |
20080172104 | Kieval et al. | Jul 2008 | A1 |
20080188912 | Stone et al. | Aug 2008 | A1 |
20080188913 | Stone et al. | Aug 2008 | A1 |
20080208162 | Joshi | Aug 2008 | A1 |
20080208169 | Boyle et al. | Aug 2008 | A1 |
20080213331 | Gelfand et al. | Sep 2008 | A1 |
20080215117 | Gross | Sep 2008 | A1 |
20080221448 | Khuri-Yakub et al. | Sep 2008 | A1 |
20080228171 | Kugler et al. | Sep 2008 | A1 |
20080234790 | Bayer et al. | Sep 2008 | A1 |
20080243091 | Humphreys et al. | Oct 2008 | A1 |
20080245371 | Gruber | Oct 2008 | A1 |
20080249525 | Lee et al. | Oct 2008 | A1 |
20080249547 | Dunn | Oct 2008 | A1 |
20080255550 | Bell | Oct 2008 | A1 |
20080255642 | Zarins et al. | Oct 2008 | A1 |
20080262489 | Steinke | Oct 2008 | A1 |
20080275484 | Gertner | Nov 2008 | A1 |
20080281312 | Werneth et al. | Nov 2008 | A1 |
20080281347 | Gertner | Nov 2008 | A1 |
20080287918 | Rosenman et al. | Nov 2008 | A1 |
20080294037 | Richter | Nov 2008 | A1 |
20080300618 | Gertner | Dec 2008 | A1 |
20080312644 | Fourkas et al. | Dec 2008 | A1 |
20080312673 | Viswanathan et al. | Dec 2008 | A1 |
20080314394 | Ellis et al. | Dec 2008 | A9 |
20080317818 | Griffith et al. | Dec 2008 | A1 |
20090018486 | Goren et al. | Jan 2009 | A1 |
20090018609 | DiLorenzo | Jan 2009 | A1 |
20090024194 | Arcot-Krishnamurthy et al. | Jan 2009 | A1 |
20090030312 | Hadjicostis | Jan 2009 | A1 |
20090036948 | Levin et al. | Feb 2009 | A1 |
20090043372 | Northrop et al. | Feb 2009 | A1 |
20090054082 | Kim et al. | Feb 2009 | A1 |
20090062873 | Wu et al. | Mar 2009 | A1 |
20090069671 | Anderson | Mar 2009 | A1 |
20090076409 | Wu et al. | Mar 2009 | A1 |
20090088735 | Abboud et al. | Apr 2009 | A1 |
20090105631 | Kieval | Apr 2009 | A1 |
20090112202 | Young | Apr 2009 | A1 |
20090118620 | Tgavalekos et al. | May 2009 | A1 |
20090118726 | Auth et al. | May 2009 | A1 |
20090125099 | Weber et al. | May 2009 | A1 |
20090131798 | Minar | May 2009 | A1 |
20090143640 | Saadat et al. | Jun 2009 | A1 |
20090156988 | Ferren et al. | Jun 2009 | A1 |
20090157057 | Ferren et al. | Jun 2009 | A1 |
20090157161 | Desai et al. | Jun 2009 | A1 |
20090171333 | Hon | Jul 2009 | A1 |
20090192558 | Whitehurst et al. | Jul 2009 | A1 |
20090198223 | Thilwind et al. | Aug 2009 | A1 |
20090203962 | Miller et al. | Aug 2009 | A1 |
20090203993 | Mangat et al. | Aug 2009 | A1 |
20090204170 | Hastings et al. | Aug 2009 | A1 |
20090210953 | Moyer et al. | Aug 2009 | A1 |
20090216317 | Cromack et al. | Aug 2009 | A1 |
20090221955 | Babaev | Sep 2009 | A1 |
20090226429 | Salcedo et al. | Sep 2009 | A1 |
20090240249 | Chan et al. | Sep 2009 | A1 |
20090247933 | Maor et al. | Oct 2009 | A1 |
20090247966 | Gunn et al. | Oct 2009 | A1 |
20090248012 | Maor et al. | Oct 2009 | A1 |
20090253974 | Rahme | Oct 2009 | A1 |
20090264755 | Chen et al. | Oct 2009 | A1 |
20090270850 | Zhou et al. | Oct 2009 | A1 |
20090281533 | Ingle et al. | Nov 2009 | A1 |
20090287137 | Crowley | Nov 2009 | A1 |
20090318749 | Stolen et al. | Dec 2009 | A1 |
20100009267 | Chase et al. | Jan 2010 | A1 |
20100030061 | Canfield et al. | Feb 2010 | A1 |
20100048983 | Ball et al. | Feb 2010 | A1 |
20100049099 | Thapliyal et al. | Feb 2010 | A1 |
20100049186 | Ingle et al. | Feb 2010 | A1 |
20100049188 | Nelson et al. | Feb 2010 | A1 |
20100049191 | Habib et al. | Feb 2010 | A1 |
20100049283 | Johnson | Feb 2010 | A1 |
20100069837 | Rassat et al. | Mar 2010 | A1 |
20100076299 | Gustus et al. | Mar 2010 | A1 |
20100076425 | Carroux | Mar 2010 | A1 |
20100087782 | Ghaffari et al. | Apr 2010 | A1 |
20100106005 | Karczmar et al. | Apr 2010 | A1 |
20100114244 | Manda et al. | May 2010 | A1 |
20100130836 | Malchano et al. | May 2010 | A1 |
20100137860 | Demarais et al. | Jun 2010 | A1 |
20100137952 | Demarais et al. | Jun 2010 | A1 |
20100160903 | Krespi | Jun 2010 | A1 |
20100160906 | Jarrard | Jun 2010 | A1 |
20100168624 | Sliwa | Jul 2010 | A1 |
20100168731 | Wu et al. | Jul 2010 | A1 |
20100168739 | Wu et al. | Jul 2010 | A1 |
20100174282 | Demarais et al. | Jul 2010 | A1 |
20100191112 | Demarais et al. | Jul 2010 | A1 |
20100191232 | Boveda | Jul 2010 | A1 |
20100217162 | Hissong et al. | Aug 2010 | A1 |
20100222786 | Kassab | Sep 2010 | A1 |
20100222851 | Deem et al. | Sep 2010 | A1 |
20100222854 | Demarais et al. | Sep 2010 | A1 |
20100228122 | Keenan et al. | Sep 2010 | A1 |
20100249604 | Hastings et al. | Sep 2010 | A1 |
20100249773 | Clark et al. | Sep 2010 | A1 |
20100256616 | Katoh et al. | Oct 2010 | A1 |
20100268217 | Habib | Oct 2010 | A1 |
20100268307 | Demarais et al. | Oct 2010 | A1 |
20100284927 | Lu et al. | Nov 2010 | A1 |
20100286684 | Hata et al. | Nov 2010 | A1 |
20100298821 | Garbagnati | Nov 2010 | A1 |
20100305036 | Barnes et al. | Dec 2010 | A1 |
20100312141 | Keast et al. | Dec 2010 | A1 |
20100324472 | Wulfman | Dec 2010 | A1 |
20110009750 | Taylor et al. | Jan 2011 | A1 |
20110021976 | Li et al. | Jan 2011 | A1 |
20110034832 | Cioanta et al. | Feb 2011 | A1 |
20110040324 | McCarthy et al. | Feb 2011 | A1 |
20110044942 | Puri et al. | Feb 2011 | A1 |
20110060324 | Wu et al. | Mar 2011 | A1 |
20110071400 | Hastings et al. | Mar 2011 | A1 |
20110071401 | Hastings et al. | Mar 2011 | A1 |
20110077498 | McDaniel | Mar 2011 | A1 |
20110092781 | Gertner | Apr 2011 | A1 |
20110092880 | Gertner | Apr 2011 | A1 |
20110104061 | Seward | May 2011 | A1 |
20110112400 | Emery et al. | May 2011 | A1 |
20110118600 | Gertner | May 2011 | A1 |
20110118726 | De La Rama et al. | May 2011 | A1 |
20110130708 | Perry et al. | Jun 2011 | A1 |
20110137155 | Weber et al. | Jun 2011 | A1 |
20110144479 | Hastings et al. | Jun 2011 | A1 |
20110146673 | Keast et al. | Jun 2011 | A1 |
20110152877 | Bly | Jun 2011 | A1 |
20110166499 | Demarais et al. | Jul 2011 | A1 |
20110178570 | Demarais | Jul 2011 | A1 |
20110200171 | Beetel et al. | Aug 2011 | A1 |
20110202098 | Demarais et al. | Aug 2011 | A1 |
20110207758 | Sobotka et al. | Aug 2011 | A1 |
20110208096 | Demarais et al. | Aug 2011 | A1 |
20110257523 | Hastings et al. | Oct 2011 | A1 |
20110257564 | Demarais et al. | Oct 2011 | A1 |
20110257622 | Salahieh et al. | Oct 2011 | A1 |
20110257641 | Hastings et al. | Oct 2011 | A1 |
20110257642 | Griggs, III | Oct 2011 | A1 |
20110263921 | Vrba et al. | Oct 2011 | A1 |
20110264011 | Wu et al. | Oct 2011 | A1 |
20110264075 | Leung et al. | Oct 2011 | A1 |
20110264086 | Ingle | Oct 2011 | A1 |
20110264116 | Kocur et al. | Oct 2011 | A1 |
20110270238 | Rizq et al. | Nov 2011 | A1 |
20110306851 | Wang | Dec 2011 | A1 |
20110319809 | Smith | Dec 2011 | A1 |
20120029496 | Smith | Feb 2012 | A1 |
20120029500 | Jenson | Feb 2012 | A1 |
20120029505 | Jenson | Feb 2012 | A1 |
20120029509 | Smith | Feb 2012 | A1 |
20120029510 | Haverkost | Feb 2012 | A1 |
20120029511 | Smith et al. | Feb 2012 | A1 |
20120029512 | Willard et al. | Feb 2012 | A1 |
20120029513 | Smith et al. | Feb 2012 | A1 |
20120059241 | Hastings et al. | Mar 2012 | A1 |
20120059286 | Hastings et al. | Mar 2012 | A1 |
20120065506 | Smith | Mar 2012 | A1 |
20120065554 | Pikus | Mar 2012 | A1 |
20120089047 | Ryba et al. | Apr 2012 | A1 |
20120095461 | Herscher et al. | Apr 2012 | A1 |
20120101413 | Beetel et al. | Apr 2012 | A1 |
20120101490 | Smith | Apr 2012 | A1 |
20120101538 | Ballakur et al. | Apr 2012 | A1 |
20120109021 | Hastings et al. | May 2012 | A1 |
20120116382 | Ku et al. | May 2012 | A1 |
20120116383 | Mauch et al. | May 2012 | A1 |
20120116392 | Willard | May 2012 | A1 |
20120116438 | Salahieh et al. | May 2012 | A1 |
20120116486 | Naga et al. | May 2012 | A1 |
20120123243 | Hastings | May 2012 | A1 |
20120123258 | Willard | May 2012 | A1 |
20120123261 | Jenson et al. | May 2012 | A1 |
20120123303 | Sogard et al. | May 2012 | A1 |
20120123406 | Edmunds et al. | May 2012 | A1 |
20120130289 | Demarais et al. | May 2012 | A1 |
20120130345 | Levin et al. | May 2012 | A1 |
20120130359 | Turovskiy | May 2012 | A1 |
20120130360 | Buckley et al. | May 2012 | A1 |
20120130362 | Hastings et al. | May 2012 | A1 |
20120130368 | Jenson | May 2012 | A1 |
20120130458 | Ryba et al. | May 2012 | A1 |
20120136344 | Buckley et al. | May 2012 | A1 |
20120136349 | Hastings | May 2012 | A1 |
20120136350 | Goshgarian et al. | May 2012 | A1 |
20120136417 | Buckley et al. | May 2012 | A1 |
20120136418 | Buckley et al. | May 2012 | A1 |
20120143181 | Demarais et al. | Jun 2012 | A1 |
20120143293 | Mauch et al. | Jun 2012 | A1 |
20120143294 | Clark et al. | Jun 2012 | A1 |
20120150267 | Buckley et al. | Jun 2012 | A1 |
20120157986 | Stone et al. | Jun 2012 | A1 |
20120157987 | Steinke et al. | Jun 2012 | A1 |
20120157988 | Stone et al. | Jun 2012 | A1 |
20120157989 | Stone et al. | Jun 2012 | A1 |
20120157992 | Smith et al. | Jun 2012 | A1 |
20120157993 | Jenson et al. | Jun 2012 | A1 |
20120158101 | Stone et al. | Jun 2012 | A1 |
20120158104 | Huynh et al. | Jun 2012 | A1 |
20120172837 | Demarais et al. | Jul 2012 | A1 |
20120172870 | Jenson et al. | Jul 2012 | A1 |
20120184952 | Jenson et al. | Jul 2012 | A1 |
20120197198 | Demarais et al. | Aug 2012 | A1 |
20120197252 | Deem et al. | Aug 2012 | A1 |
20120221014 | Stack et al. | Aug 2012 | A1 |
20120232409 | Stahmann et al. | Sep 2012 | A1 |
20120265066 | Crow et al. | Oct 2012 | A1 |
20120265198 | Crow et al. | Oct 2012 | A1 |
20130012844 | Demarais et al. | Jan 2013 | A1 |
20130012866 | Deem et al. | Jan 2013 | A1 |
20130012867 | Demarais et al. | Jan 2013 | A1 |
20130013024 | Levin et al. | Jan 2013 | A1 |
20130018247 | Glenn et al. | Jan 2013 | A1 |
20130018444 | Glenn et al. | Jan 2013 | A1 |
20130023865 | Steinke et al. | Jan 2013 | A1 |
20130035681 | Subramanaim et al. | Feb 2013 | A1 |
20130066316 | Steinke et al. | Mar 2013 | A1 |
20130085489 | Fain et al. | Apr 2013 | A1 |
20130090563 | Weber | Apr 2013 | A1 |
20130090578 | Smith et al. | Apr 2013 | A1 |
20130090647 | Smith | Apr 2013 | A1 |
20130090649 | Smith et al. | Apr 2013 | A1 |
20130090650 | Jenson et al. | Apr 2013 | A1 |
20130090651 | Smith | Apr 2013 | A1 |
20130090652 | Jenson | Apr 2013 | A1 |
20130096550 | Hill | Apr 2013 | A1 |
20130096553 | Hill et al. | Apr 2013 | A1 |
20130096554 | Groff et al. | Apr 2013 | A1 |
20130096604 | Hanson et al. | Apr 2013 | A1 |
20130110106 | Richardson | May 2013 | A1 |
20130116687 | Willard | May 2013 | A1 |
20130165764 | Scheuermann et al. | Jun 2013 | A1 |
20130165844 | Shuros et al. | Jun 2013 | A1 |
20130165916 | Mathur et al. | Jun 2013 | A1 |
20130165917 | Mathur et al. | Jun 2013 | A1 |
20130165920 | Weber et al. | Jun 2013 | A1 |
20130165923 | Mathur et al. | Jun 2013 | A1 |
20130165924 | Mathur et al. | Jun 2013 | A1 |
20130165925 | Mathur et al. | Jun 2013 | A1 |
20130165926 | Mathur et al. | Jun 2013 | A1 |
20130165990 | Mathur et al. | Jun 2013 | A1 |
20130172815 | Perry et al. | Jul 2013 | A1 |
20130172872 | Subramaniam et al. | Jul 2013 | A1 |
20130172877 | Subramaniam et al. | Jul 2013 | A1 |
20130172878 | Smith | Jul 2013 | A1 |
20130172879 | Sutermeister | Jul 2013 | A1 |
20130172880 | Willard | Jul 2013 | A1 |
20130172881 | Hill et al. | Jul 2013 | A1 |
Number | Date | Country |
---|---|---|
10038737 | Feb 2002 | DE |
1053720 | Nov 2000 | EP |
1180004 | Feb 2002 | EP |
1335677 | Aug 2003 | EP |
1874211 | Jan 2008 | EP |
1906853 | Apr 2008 | EP |
1961394 | Aug 2008 | EP |
1620156 | Jul 2009 | EP |
2076193 | Jul 2009 | EP |
2091455 | Aug 2009 | EP |
2197533 | Jun 2010 | EP |
2208506 | Jul 2010 | EP |
1579889 | Aug 2010 | EP |
2092957 | Jan 2011 | EP |
2349044 | Aug 2011 | EP |
2027882 | Oct 2011 | EP |
2378956 | Oct 2011 | EP |
2037840 | Dec 2011 | EP |
2204134 | Apr 2012 | EP |
2320821 | Oct 2012 | EP |
2456301 | Jul 2009 | GB |
9858588 | Dec 1998 | WO |
9900060 | Jan 1999 | WO |
0047118 | Aug 2000 | WO |
03026525 | Apr 2003 | WO |
2004100813 | Nov 2004 | WO |
2004110258 | Dec 2004 | WO |
2006105121 | Oct 2006 | WO |
2007033052 | Mar 2007 | WO |
2008014465 | Jan 2008 | WO |
2009121017 | Oct 2009 | WO |
2010067360 | Jun 2010 | WO |
2010102310 | Sep 2010 | WO |
2011005901 | Jan 2011 | WO |
2011053757 | May 2011 | WO |
2011053772 | May 2011 | WO |
2011091069 | Jul 2011 | WO |
2011130534 | Oct 2011 | WO |
2012019156 | Feb 2012 | WO |
2013049601 | Apr 2013 | WO |
Entry |
---|
US 8,398,630 B2, 03/2013, Demarais et al. (withdrawn) |
Van Den Berg, “Light echoes image the human body,” OLE, Oct. 2001, p. 35-37. |
“IntraLuminal: Products,” IntraLuminal Therapeutics, Inc., 2003, p. 1-9. |
“Laser Catheter to Aid Coronary Surgery,” TechTalk: MIT, Jan. 9, 1991, p. 1-4. |
“Optical Coherence Tomography: Advantages of OCT,” LightLab Imaging Technology, printed Sep. 3, 2003. |
“Optical Coherence Tomography: Image Gallery Cardiovascular Procedures,” LightLab Imaging Technology, printed Sep. 3, 2003. |
“Optical Coherence Tomography: LightLab Imaging Starts US Cardiology Clinical Investigations,” LightLab Imaging Technology, 2002. |
“Optical Coherence Tomography: LightLab Sees Bright Prospects for Cardiac Application of OCT Technology,” LightLab Imaging Technology, 2001, vol. 27, No. 35. |
“Optical Coherence Tomography: What is OCT?,” LightLab Imaging Technology, printed Sep. 3, 2003. |
“Optical Coherence Tomography: Why Use OCT?,” LightLab Imaging Technology, printed Sep. 3, 2003. |
“Products—Functional Measurement,” VOLCANO Functional Measurement Products US, Mar. 24, 2003, p. 1-2. |
Brown et al., “Radiofrequency capacitive heaters: the effect of coupling medium resistivity on power absorption along a mouse leg,” Physics in Medicine and Biology, 1993, p. 1-12, vol. 38. |
Carrington, “Future of CVI: It's all about plaque: Identification of vulnerable lesions, not ‘rusty pipes,’ could become cornerstone of preventive cardiology,” Diagnostic Imaging, 2001, p. 1-8. |
Chen et al., “Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo,” EuroIntervention, 2013, p. 1-8. |
Cimino, “Preventing plaque attack,” Mass High Tech, 2001, p. 1-2. |
Dahm et al., “Relation of Degree of Laser Debulking of In-Stent Restenosis as a Predictor of Restenosis Rate,” The American Journal of Cardiology, 2002, p. 68-70, vol. 90. |
De Korte et al., “Characterization of Plaque Components With Intravascular Ultrasound Elastography in Human Femoral and Coronary Arteries In Vitro,” Circulation, Aug. 8, 2000, p. 617-623. |
Durney et al., “Radiofrequency Radiation Dosimetry Handbook,” Oct. 1986, p. 1-2, Fourth Edition. |
Durney et al., “Radiofrequency Radiation Dosimetry Handbook: Contents,” Oct. 1986, p. 1-5, Fourth Edition. |
Fournier-Desseux et al., “Assessment of 1-lead and 2-lead electrode patterns in electrical impedance endotomography,” Physiological Measurement, 2005, p. 337-349. Vo. 26, Institute of Physics Publishing. |
Fram et al., “Feasibility of Radiofrequency Powered, Thermal Balloon Ablation of Atrioventricular Bypass Tracts via the Coronary Sinus: In Vivo Canine Studies,” PACE, Aug. 1995, p. 1518-1530, vol. 18. |
Fram et al., “Low Pressure Radiofrequency Balloon Angioplasty: Evaluation in Porcine Peripheral Arteries,” JACC, 1993, p. 1512-1521, vol. 21, No. 6, American College of Cardiology. |
Fujimori et al., “Significant Prevention of In-Stent Restenosis by Evans Blue in Patients with Acute Myocardial Infarction,” American Heart Association, 2002. |
Fujita et al., “Sarpogrelate, An Antagonist of 5-HT(2A) Receptor, Treatment Reduces Restenosis After Coronary Stenting,” American Heart Association, 2002. |
Gabriel, “Appendix A: Experimental Data,” 1999, p. 1-21. |
Gabriel, “Appendix C: Modeling the frequency dependence of the dielectric properties to a 4 dispersions spectrum,” p. 1-6, Nov. 6, 1997. |
Gregory et al., “Liquid Core Light Guide for Laser Angioplasty,” The Journal of Quantum Electronics, Dec. 1990, p. 2289-2296, vol. 26, No. 12. |
Kaplan et al., “Healing after Arterial Dilatation with Radiofrequency Thermal and Nonthermal Balloon Angioplasty Sytems,” Journal of Investigative Surgery, 1993, p. 33-52, vol. 6. |
Kolata, “New Studies Question Value of Opening Arteries,” The New York Times, Mar. 21, 2004, p. 1-5. |
Konings et al., “Development of an Intravascular Impedance Catheter for Detection of Fatty Lesions in Arteries,” IEEE Transactions on Medical Imaging, Aug. 1997, p. 439-446, vol. 16, No. 4. |
Kurtz et al., “Lamellar Refractive Surgery with Scanned Intrastromal Picosecond and Femtosecond Laser Pulses in Animal Eyes,” Journal of Refractive Surgery, Sep./Oct. 1998, p. 541-548. |
Lee et al., “Thermal Compression and Molding of Atherosclerotic Vascular Tissue With Use of Radiofrequency Energy: Implications for Radiofrequency Balloon Angioplasty,” JACC, 1989, p. 1167-1175, vol. 13, No. 5, American College of Cardiology. |
Lima et al., “Efficacy and Safety of Oral Sirolimus to Treat and Prevent In-Stent Restenosis: A Pilot Study Results,” American Heart Association, 2002, p. 2929. |
Lima et al., “Systemic Immunosuppression Inhibits In-Stent Coronary Intimal Proliferation in Renal Transplant Patients,” American Heart Association, 2002, p. 2928. |
Morice et al., “A Randomized Comparison of a Sirolimus-Eluting Stent With a Standard Stent for Coronary Revascularization,” The New England Journal of Medicine, Jun. 6, 2012, p. 1773-1780, vol. 346, No. 23. |
Muller-Leisse et al., “Effectiveness and Safety of Ultrasonic Atherosclerotic Plaque Ablation: In Vitro Investigation,” CardioVascular and Interventional Radiology, 1993, p. 303-307, vol. 16. |
Nair et al., “Regularized Autoregressive Analysis of Intravascular Ultrasound Backscatter: Improvement in Spatial Accuracy of Tissue Maps,” IEEE Transactions on Ultrasonics, Apr. 2004, p. 420-431, vol. 51, No. 4. |
Popma et al., “Percutaneous Coronary and Valvular Intervention,” p. 1364-1405, 2005. |
Resar et al., “Endoluminal Sealing of Vascular Wall Disruptions With Radiofrequency-Heated Balloon Angioplasty,” Catheterization and Cardiovascular Diagnosis, 1993, p. 161-167, vol. 29. |
Romer et al., “Histopathology of Human Coronary Atherosclerosis by Quantifying Its Chemical Composition With Raman Spectroscopy,” Circulation, 1998, p. 878-885, vol. 97. |
Schauerte et al., “Catheter Ablation of Cardiac Autonomic Nerves for Prevention of Vagal Atrial Fibrillation,” Circulation, 2000, p. 2774-2780, vol. 102. |
Scheller et al., “Intracoronary Paclitaxel Added to Contrast Media Inhibits In-Stent Restenosis of Porcine Coronary Arteries,” American Heart Association, 2002, p. 2227. |
Scheller et al., “Potential solutions to the current problem: coated balloon,” EuroIntervention, 2008, p. C63-C66, vol. 4 (Supplement C). |
Shaffer, “Scientific basis of laser energy,” Clinics in Sports Medicine, 2002, p. 585-598, vol. 21. |
Shmatukha et al., “MRI temperature mapping during thermal balloon angioplasty,” Physics in Medicine and Biology, 2006, p. N163-N171, vol. 51. |
Slager et al., “Vaporization of Atherosclerotic Plaques by Spark Erosion,” J Am Coll Cardiol, 1985, p. 21-25. |
Stiles et al., “Simulated Characterization of Atherosclerotic Lesions in the Coronary Arteries by Measurement of Bioimpedance,” IEEE Transactions on Biomedical Engineering, Jul. 2003, p. 916-921, vol. 50, No. 7. |
Suselbeck et al., “In vivo intravascular electric impedance spectroscopy using a new catheter with integrated microelectrodes,” Basic Res Cardiol, 2005, p. 28-34, vol. 100. |
Suselbeck et al., “Intravascular electric impedance spectroscopy of atherosclerotic lesions using a new impedance catheter system,” Basic Res Cardiol, 2005, p. 446-452, vol. 100. |
Tepe et al., “Local Delivery of Paclitaxel to Inhibit Restenosis during Angioplasty of the Leg,” The New England Journal of Medicine, 2008, p. 689-699, vol. 358. |
CardioVascular Technologies Inc., “Heated Balloon Device Technology,” 11 pages, 2008. |
Strategic Business Development, Inc., “Thermal and Disruptive Angioplasty: A Physician's Guide,” 8 pages, 1990. |
Zhang et al., “Non-contact Radio-Frequency Ablation for Obtaining Deeper Lesions,” IEEE Transaction on Biomedical Engineering, vol. 50, No. 2, 6 pages, Feb. 2003. |
Lazebnik et al., “Tissue Strain Analytics Virtual Touch Tissue Imaging and Qualification,” Siemens Whitepaper, Oct. 2008, 7 pages. |
Han et al., “Third-Generation Cryosurgery for Primary and Recurrent Prostate Caner,” BJU International, vol. 93, pp. 14-18, 2004. |
Zhou et al., “Mechanism Research of Cryoanalgesia,” Forefront Publishing Group, 1995. |
Florete, “Cryoblative Procedure for Back Pain,” Jacksonville Medicine, Oct. 1998, 10 pages. |
Stevenson, “Irrigated RF Ablation: Power Titration and Fluid Management for Optimal Safety Efficacy,” 2005, 4 pages. |
Giliatt et al., “The Cause of Nerve Damage in Acute Compression,” Trans Am Neurol Assoc, 1974: 99; 71-4. |
Omura et al., “A Mild Acute Compression Induces Neurapraxia in Rat Sciatic Nerve,” The International Journal of Neuroscience, vol. 114 (12), pp. 1561-1572, Dec. 2004. |
Baun, “Interaction with Soft Tissue,” Principles of General & Vascular Sonography, Chapter 2, pp. 23-24, Before Mar. 2012. |
Blue Cross Blue Shield Medicaly Policy, “Surgery Section—MRI-Guided Focused Ultrasound (MRgFUS) for the Treatment of Uterine Fibroids and Other Tumors,” 2005, 5 pages. |
Gentry et al., “Combines 3D Intracardiac Echo and Ultrasound Ablation,” Medical Imaging 2003: Ultrasonic and Signal Processing, vol. 5035, 2003, pp. 166-173. |
Lafon et al., “Optmizing the Shape of Ultrasound Transducers for Interstitial Thermal Ablations,” MEd Phys. Mar. 2002; 29(3): 290-7 (abstract only). |
G. Ter Haar, “Ultrasound Focal Beam Surgery,” Ultrasound in Med. & Biol., 1995, vol. 21, No. 9, pp. 1089-1100. |
Seip et al., “Transurethral High Intensity Focused Ultrasound: Catheter Based Prototypes and Experimental Results,” IEEE Ultrasonics Symposium Proceeding, 2000, 4 pages. |
Toytman et al., “Tissue Dissection with Ultrafast Laser Using Extended and Multiple Foci,” SPIE Proceeding, Optical Interactions with Tissues and Cells XXI, vol. 7562, 2010, 10 pages. |
Zhoue et al., “Non-Thermal Ablation of Rabbit Liver VX2 Tumore by Pulsed High Intensity Focused Ultrasound Contrast Agent: Pathological Characteristics,” World Journal of Gastroenterology, vol. 14(43), Nov. 21, 2008, pp. 6743-6747. |
Number | Date | Country | |
---|---|---|---|
20140276752 A1 | Sep 2014 | US |
Number | Date | Country | |
---|---|---|---|
61794020 | Mar 2013 | US |